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Pathogenic Escherichia coli, including diarrheagenic E. coli (DEC) and 
extraintestinal pathogenic E. coli (ExPEC), cause numerous human infections 
annually. Retail meats are generally contaminated with E. coli and may serve as a 
vehicle transmitting pathogenic E. coli. The objectives of this project were to detect 
and characterize different pathogenic E. coli from retail meats, and to explore their 
potential in causing human infections. 
E. coli isolates recovered from ground beef, ground turkey, chicken breast and 
pork chop during 2002 to 2007 were screened for Shiga toxin genes and Shiga toxin-
producing E. coli (STEC) were characterized phenotypically and genotypically. In 
addition, E. coli isolates recovered in 2006 were also examined for virulence genes 
specific for other DEC. The results demonstrated that retail meats, especially ground 
beef, were contaminated with diverse STEC strains and some strains contained Shiga 
toxin genes associated with severe human infections. The presence of atypical 
  
enteropathogenic E. coli in retail meat is also of concern due to their potential to 
cause human infections. 
Meanwhile, E. coli isolates recovered in 2006 were investigated for the 
presence of five ExPEC-defining virulence genes using multiplex PCR. Identified 
ExPEC isolates were characterized by serotyping and phylogenetic grouping, and 
their antimicrobial susceptibility data were analyzed. The findings showed that 
ExPEC, including antimicrobial resistant strains, were widely distributed in retail 
meats, especially in chicken and turkey products. This indicates that meat may be a 
vehicle for dissemination of ExPEC strains. 
ExPEC strains identified were further examined by multiplex PCR for the 
presence of 21 uropathogenic E. coli (UPEC) virulence genes. Selected strains were 
further characterized by multi-locus sequence typing and studied for their interactions 
with human bladder epithelial cells. Data showed that most UPEC virulence genes 
selected could be detected in isolates from meat. And some isolates belonged to 
sequence types associated with clinical UPEC. Meat-source isolates exhibited lower 
level of adherence and invasion compared to a clinical UPEC strain. These 
observations suggested that a small proportion of E. coli isolates from retail meats 
resemble human UPEC in various aspects, but their potential in causing human UTI 
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CHAPTER I.  LITERATURE REVIEW 
Escherichia coli (E. coli) are commonly found in the intestinal flora of humans and 
animals. They were recognized as non-pathogenic until late 1950s. However, certain 
isolates of E. coli have been implicated in a wide range of diseases that inflict humans 
and animals. It was estimated that each year in the United States, there are 
approximately 269,060 foodborne illness caused by enteric E. coli (46). In addition, 
E. coli infections outside the intestinal tract ranged from 6.7 to 8.6 million cases at an 
annual cost of around 1.5-2.3 billion dollars (59). Food originating from warm 
blooded animals may be contaminated with E. coli and are well known for 
transmitting certain enteric E. coli. Strains causing non-enteric infections are 
generally not considered being transmitted through food, but it was recently 
suggested that food may play a role in spreading them to humans. This chapter 
reviews basic characteristics and classification of E. coli. Moreover, the 
epidemiology, pathogenesis, treatment, transmission and detection of different 
pathotypes of E. coli are described. An overview of the project is presented at the end. 
General characteristics of E. coli   
E. coli are Gram-negative, facultative anaerobic bacteria that belong to the 
Enterobacteriaceae family. E. coli cells are typically rod-shaped and about 2 µm long 
and 0.5 µm in diameter. Optimal growth occurs at 37 °C and growth could be 
supported by aerobic and anaerobic respiration. Some strains possess flagella which 




reactions and the indole test remains the most useful method to differentiate E. coli 
from other members of the Enterobacteriaceae. 
Classification of pathogenic E. coli   
E. coli is a major component of the normal intestinal flora of humans and other 
mammals. These commensal E. coli strains from the normal intestinal flora are 
usually harmless to the host and only cause disease in immunocompromised hosts or 
when the gastrointestinal barriers are breached. However, some specific E. coli strains 
represent primary pathogens with an enhanced potential to cause disease after 
acquiring specific virulence attributes. These virulence attributes are normally 
encoded on genetic elements that can be exchanged between different strains or on 
those elements once having been mobile but later becoming fixed into the genome. 
Specific combinations of virulence factors form different pathotypes: a group of 
strains of a single species that cause a related disease using the same set of virulence 
factors. Based on the various human diseases which E. coli can cause, pathogenic E. 
coli have been broadly classified into two major categories: the diarrheagenic E. coli 
and the extraintestinal pathogenic E. coli. Among the diarrheagenic E. coli, there are 
currently six categories: enteropathogenic E. coli (EPEC), enterohemorrhagic E. coli 
(EHEC)/Shiga toxin-producing E. coli (STEC), enterotoxigenic E. coli (ETEC), 
enteroinvasive E. coli (EIEC), enteroaggregative E. coli (EAEC), and diffusively 
adherent E. coli (DAEC) (32). Extraintestinal pathogenic E. coli are phylogenetically 
and epidemiologically distinct from diarrheagenic E. coli. They could colonize a 
variety of anatomical locations and cause various infections outside the 




The E. coli strains causing extraintestinal infections have been collectively called 
extraintestinal pathogenic E. coli (ExPEC), which includes two major pathotypes: 
uropathogenic E. coli (UPEC) and neonatal meningitis E. coli (NMEC). Current 
understanding of different pathogenic E. coli except NMEC will be discussed in 
detail below. 
EPEC 
Enteropathogenic E. coli is a leading cause of potentially fatal infant diarrhea 
in developing countries and also an important cause of diarrhea in industrialized 
countries. EPEC infection is primarily a disease in infants younger than 2 years. 
Sporadic disease also occurred in some adults with compromising conditions. Once 
defined only on O and H serotyping, they are currently defined by pathogenic features 
as those diarrheagenic E. coli that induce attaching and effacing (A/E) lesions on 
intestinal cells and do not produce Shiga toxins. They could be divided into typical 
EPEC and atypical EPEC based on the presence of EPEC adherence factors (EAF) 
plasmid. Molecularl detection and differentiation of EPEC could be based on the eae 
gene (A/E lesions) and bfp gene (which resides on EAF plasmids and encodes 
bundle- forming pilus). Typical EPEC contain both eae and bfp genes, while atypical 
EPEC contain only eae gene. Typical EPEC infections are common in developing 
countries while atypical E. coli seems to predominate in the industrialized countries 
(8, 67). Not like typical EPEC which are found only in human so far, atypical EPEC 
have been isolated from a variety of animal species such as cattle, goats, sheep, 




Pathogenesis of EPEC is currently considered to include four stages: 
expression of adhesion factors, initial localized adherence, signal transduction and 
intimate contact, cytoskeletal rearrangement and pedestal formation. Initally the 
bacteria attach to intestinal epithelial cells by adhesive fimbriae called bundle 
forming pili (BFP) or EPEC adherence factor (EAF) (18).  EPEC also adhere to 
epithelial cells by expressing intimin (encoded by eae gene) and surface–associated 
filament EspA (34). After initial binding, EPEC utilize type III secretion system to 
inject into host cells translocated initmin receptor (TIR) and several effector 
molecules, which activate cell signaling pathways and actin polymerization and 
depolymerization to alter cytoskeletal structure. TIR is then phosphorylated and 
inserted into the host cell membrane for later intimate contact.   Activated host cell 
signal transduction pathway causes extensive rearrangement of actin, which results in 
the formation of the characteristic attaching and effacing lesions (33). The membrane 
under the bacteria forms a pedestal due to host cell cytoskeletal rearrangement. The 
microvilli are lost due to depolymerization of actin filament in microvilli. The 
effector proteins also influence membrance permeability and cause diarrhea-
associated symptoms.  Virulence genes in EPEC are mostly located in a pathogenic 
island called locus of enterocyte effacement (LEE). 
EHEC/STEC 
The EHEC group is also referred to Shiga-toxin producing E. coli (STEC) 
because its pathogenicity is largely attributed to the production of Shiga toxins. It 
should be noted that some researchers prefer to use EHEC only for those STEC 




broader term STEC later in this project. Among six categories of diarrheagenic 
strains, STEC strains distinguish themselves by their ability to cause severe life-
threatening complications, such as hemolytic uremic syndrome (HUS) and thrombotic 
thrombocytopenic purpura(TTP). Other symptoms of STEC infection include bloody 
diarrhea and hemorrhagic colitis (HC). Children and the elderly are more susceptible 
to severe STEC infections than healthy adults. Outbreaks and sporadic cases of STEC 
infections are frequently reported worldwide, indicating the great threat that STEC 
could pose for human health (10, 22, 74, 78). 
STEC can be disseminated through a variety of means. Most human infections 
are caused by consumption of contaminated foods. Domestic and wild ruminant 
animals, in particular cattle, are considered as the main reservoir of STEC and the 
main source for contamination of the food supply (1, 23, 25). Food products derived 
from these animals can be contaminated with STEC during slaughter and further 
processing. In addition, vegetables contaminated with cattle manure have been also 
implicated in many cases and outbreaks of STEC infections (56, 73). STEC have 
been also isolated from other food animals such as pigs and poultry, but whether 
these animals represent real hosts or are just temporarily colonized with STEC is not 
clear (9, 19). 
The mechanisms of STEC infection in humans are not fully understood. The 
major virulence factors implicated in STEC infection are potent Shiga toxins, which 
are classified into two groups: Stx1 and Stx2.  In each group, variants that differ in 
toxicity, toxin receptor, and amino acid sequences have been described. Few variants 




including Stx2c, Stx2d, Stx2e, Stx2f, Stx2g (26, 51, 65, 66, 72). Shiga toxin types 
were suggested to correlate with the clinical symptoms of STEC infection.  Some Stx 
types, such as Stx2, Stx2c and Stx2d-activatable, have been associated with high 
virulence and ability to cause HUS, while Stx1, Stx1c, Stx2e occurred mainly in 
milder diarrhea patients or asymptomatic carriers (13).  In addition to Stx production, 
other (putative) virulence factors that could contribute to the pathogenicity have been 
discovered. The eae gene, which is located in a pathogenic island in the chromosome 
called the locus of enterocyte effacement (LEE), is the best characterized virulence 
loci other than stx. The eae gene encodes the adherence factor intimin, an outer 
membrane protein involved in the attachment of E. coli to the enterocyte. In addition, 
many pathogenic STEC possess a large plasmid that harbors several putative 
virulence factors such as EHEC-hlyA, which encode for a cytolytic EHEC-hemolysin. 
EHEC hemolysin is strongly associated with STEC isolates causing severe infections 
in human, but its exact role in pathogenesis is still yet to be known. 
More than 400 serotypes of STEC strains have been implicated in human 
infections (7). Although E. coli O157: H7 is considered the principal STEC in the U. 
S., infections due to non-O157 STEC occurr and are thought to be underreported (5, 
53).  In some other countries, such as Germany, Australia, and the UK, non-O157 
STEC infections predominate (4, 79). Globally, only a limited numbers of serotypes 
were frequently observed and are responsible for the majority of STEC infections.  
ETEC 
ETEC are defined as those E. coli strains that contain at least one of two 




ETEC is an important cause of childhood diarrhea in developing countries due to 
poor sanitary conditions. It is also a common cause of diarrhea in travelers to 
developing countries (55). It is estimated that around 650 million cases of ETEC 
infection occur each year in developing countries, which include 800,000 deaths 
mostly in young children (55). It causes watery diarrhea ranging from mild form to 
severe purging disease. The diarrhea persists for 3-4 days and is usually self-limiting, 
however, diarrhea may be fatal in young children and infants. Epidemiologic studies 
found that contaminated food and water serves as the most common vehicles for 
ETEC infections, and fecal contamination of water and food is the primary reason for 
high incidence of ETEC infection in the developing countries (37, 80). 
Colonization factors (CF) and one or more enterotoxins that induce a 
secretory diarrhea are the major determinants of ETEC virulence.  CFs are 
proteinaceous fimbrial and afimbrial structures that enable bacteria to attach to 
intestinal mucosa. More than 20 CFs have been identified and characterized in ETEC 
(75). Other adhesion factors such as TibA (an afimbrial adhesion) and Tia (an outer 
membrane protein) are also involved and implicated in the attachment of  ETEC (41). 
 Having established contact with epithelial cells, ETEC can produce one or 
more ST or LT. ST have been divided into two distinct groups: methanol soluble STI 
(or STa) and methanol insoluble STII (or STb) (57). STa toxins have two genetic 
variants STh and STp, described originally in association with strains isolated from 
human and pigs, respectively. However, new studies found that both variants could be 
found in ETEC strains of human origin. STa binds to guanylate cyclase C receptor 




intracellular cGMP level. Increase cGMP influences ion pumps, resulting in enhanced 
salt and water secretion and inhibition of Na+ absorption. STb is most associated with 
porcine strains of ETEC.  
LT is an oligomeric protein composed by a ring of five identical B subunits 
with one A subunit. The B subunits bind to a GTP binding protein (ganglioside 
receptor), while the A subunit is responsible for the enzymatic activity of the toxin 
(21). Based on type of cell surface receptor to which B subunits bind, LT could be 
divided into LT-I (bind to ganglioside receptor GM1) and LT-II (bind to ganglioside 
receptor GD1).  A subunit ADP-ribosylates the alpha subunit of the GTP-binding 
protein Gs, leading to activation of adenylate cyclase in the enterocyte and 
accumulation of cyclic AMP. The increase in intracellular cAMP increases Cl- 
secretion in crypt cells and decreases absorption of Na+ and Cl- by villus tip cells. 
Other toxins that may contribute to ETEC infection include a novel heat stable 
enterotoxin EAST1 and a serine protease autotransporter, EatA, and a pore–forming 
toxin, ClyA. 
EIEC 
EIEC strains are genetically and pathogenically related closely to Shigella 
spp. (54). EIEC infections mostly produce watery diarrhea that is indistinguishable 
from other E. coli, although they may induce invasive inflammatory colitis and 
dysentery. Sporadic outbreaks are common and those outbreaks are usually foodborne 
or waterborne (71).  
EIEC invade colonic epithelial cells, followed by lysis of endocytic vesicle, 




adjacent cells. Genes required for invasions are present on a plasmid called pInv. 
Much of the EIEC pathogenesis can be attributed to a type III secretion system, which 
encodes many effector proteins such as IpaA, IpaB IpaC and IpgD. These loci 
mediate epithelial signaling events, cytoskeletal rearrangement, cellular uptake, lysis 
of the endocytic vacuole and other processes (77).  
EAEC 
EAEC are defined as E. coli that do not produce LT or ST and that adhere to 
HEp-2 cells in a pattern described as autoaggregative. EAEC have been increasingly 
recognized as an important causative agent of persistent diarrhea in children and 
adults in both developing and developed countries. EAEC mostly cause sporadic 
cases, but several outbreaks have been reported (69). 
Pathogenesis of EAEC includes colonization of intestinal mucosa by adhesins 
followed by secretion of enterotoxins and cytotoxins (62). EAEC express aggregative 
adherence fimbriae (AAF) I, II and III and outer membrane adhesion proteins. 
Adherence is described as a stacked-brick shape. EAEC elaborate enteroaggregative 
heat stable toxin (EAST) and a cytotoxin that is responsible for pathological effects. 
Infections usually lead to mucoid stool and persistent diarrhea (often more than 14 
days). 
DAEC 
The most recently distinguished category in DEC are the diffuse adherent E. 
coli (DAEC), strains that are capable of adhering to HEp-2 cells in a nonlocalized 
(diffuse) pattern. DAEC have been implicated in infantile diarrhea (63). It cause 




Pathogenesis of DAEC is largely unknown. Most of DAEC produce a fimbrial 
adhesion called F1845, a member of the Dr family of adhesins, which is thought to be 
partly responsible for diffuse adherence pattern. DAEC strains elicit a cytopathic 
effect characterized by the development of long cellular extension which wrap around 
the bacteria. DAEC have also been shown to impair the activities and synthesis of 
brush-border-associated hydrolysase, which implies the existence of pathogenic 
mechanisms other than Dr adhesins (3). 
ExPEC 
The E. coli pathotypes that cause extraintestinal infections are collectively 
called ExPEC. They are phylogenetically and epidemiologically distinct from 
commensal and diarrheagenic stains. Compared to human commensal strains, which 
usually derive from phylogenetic groups A and B1, most of ExPEC strains belong to 
the B2 and D groups and harbor various virulence factors which allow them to induce 
diseases in both healthy and compromised hosts (59, 60). Based on the prevalence of 
various virulence factors in clinical E. coli isolates from extraintestinal infections, 
ExPEC were currently defined as E. coli isolates containing two or more of the 
following genes: papA (P fimbriae structural subunit) and/or papC (P fimbriae 
assembly), sfa/foc (S and F1C fimbriae subunits), afa/dra (Dr-antigen-binding 
adhesins), kpsMT II (group 2 capsular polysaccharide units), and iutA (aerobactin 
receptor) (31). 
Unlike diarrheagenic strains, ExPEC are incapable of causing gastrointestinal 
disease in human. However, ExPEC can cause diverse infections at different 




common cause of urinary tract infections and one of the leading causes of neonatal 
meningitis and neonatal sepsis. In addition, E. coli can be implicated in community-
acquired bacteremia and sepsis. E. coli also occur in intra-abdominal infections and 
nosocomial pneumonia, and occasionally are involved in other extraintestinal 
infections such as osteomyelitis, cellulitis, and wound infections.   
UPEC 
Urinary tract infections are the most common bacterial infections, which 
account for approximately seven billion infections per year and over $1 billion cost . 
Uropathogenic E. coli (UPEC), which belong to the ExPEC, are the principal cause of 
community-acquired urinary tract infections (UTI) (70–95%) and a large portion of 
nosocomial UTIs (50%) in the U. S. (16). 
It is generally accepted that a primary reservoir of UPEC isolates is within the 
human intestinal tract (61). Due to the proximity of urinary tract to the rectum, 
bacteria can be transferred to the urinary tract, where they ascend the urethra into the 
bladder and cause cystitis. Sometimes bacteria find their way through ureters to 
kidney and cause pyelonephritis. Normally UPEC cause sporadic cases and outbreaks 
due to the same strain are rare. But transimission of a single clonal group of UPEC 
isolates may occur in a community by contaminated food or other consumables (44). 
UPEC from UTI patients often match fecal isolates from their sex partners, 
suggesting that UPEC could be sexually transmitted (17). 
Most UPEC strains belong to  limited serogroups based on their O-antigen 
(O1, O2, O4, O6, O7, O8, O16, O18, O25, O75), while specific K and H antigens 




to survival for some UPEC strains, although how the O antigen enhances UPEC 
virulence still needs exploring. UPEC encode various adhesive structures called pili 
and fimbriae, among which are type 1, P, S, F1C pili (70). One UPEC strain can 
harbor several different pili and be able to switch from one type of pilus to another 
depending on the environmental changes. To survive in a low iron environment such 
as the urinary tract, UPEC express different iron acquisition systems to take iron from 
host for their benefit. They secrete siderophores such as aerobactin, salmochelin, and 
yersiniabactin that can scavenge iron from the environment and then be taken back to 
bacteria through receptors on the bacterial cell surface. Various toxins that UPEC 
secrete are involved in UTI pathogenesis. More than half of UPEC isolates contain 
alpha-hemolysin (HlyA), which can form pores in host cells. Vacuolating 
autotransporter toxin (Vat) and secreted autotransporter toxin (Sat) are considered as 
potential virulence factors due to their ability to cause vacuolating and swelling. 
Another important toxin that UPEC elaborate is cytotoxic necrotizing factor 
1(CNF1), which is found in one third of UPEC isolates. CNF1 can activate the Rho 
family of GTPases, leading to membrane ruffling, modulation of inflammatory 
signaling pathways and apoptosis (40). Many UPEC virulence genes are encoded on 
pathogenic islands, in which many virulence genes may be clustered together. 
Upon arriving at the urinary tract, UPEC must first bind to host epithelial cells 
to avoid clearance by the flow of urine. UPEC achieve this by expressing pili or 
fimbriae (27). The most common pili with UPEC are type 1, S/F1C and the Dr family 
of adhesins. These pili are assembled by periplasmic chaperone protein and outer-




which are encoded by many UPEC strains. Type 1 pili, through its adhesive tip FimH, 
bind to mannosylated glycoprotein receptors expressed by a number of host epithelial 
cells and are considered the most important virulence factor in the pathogenesis of 
UTI. Although many commensal E. coli also encode type 1 pili, FimH in commensal 
stains only bind to trimannose receptors, while 70% of UPEC express FimH variants 
with higher affinity for monomannose receptors in uroepithelial cells. Type P pili are 
commonly associated with pyelonephritis. Their tip protein, PapG, binds to a 
glycolipid receptor called globotriasylceramid (GbO3) and its variants expressed on 
the surface of kidney cells. In addition to type 1 and P pili, other groups of  pili are 
also found to be associated with adherence of UPEC to host cells. S pili use SfaS tip 
to interact with sialic acid residue of receptors on kidney epithelial cells and vascular 
endothelial cells and are often associated with strains causing ascending UTIs, sepsis 
and meningitis. F1C pili, which are homologous to S pili but with different receptor 
specificity, may also influence pathogenesis of many UPEC strains. Dr adhesion 
family include the uropathogen- associated fimbrial adhesion Dr and non-fimbrial 
adhesion such as AFA I to IV. Members of Dr adhesins recognize one or more of 60 
amino acid short consensus repeat sequence, which are present in receptors on the 
uroepithelia. They are thought to contribute to ascending colonization and chronic 
interstitial infections of the urinary tract.  
After colonizing the urinary tract through binding to host cells, UPEC invade 
epithelial cells. UPEC invasion of host cells was postulated to enhance bacterial 
survival by protecting themselves from host immune defenses and allowing them to 




proposed as contributing factors that promote invasion of host cells by activating host 
cell signaling events. Within epithelial cells, UPEC are transported into acidic 
compartments with features like late endosomes or lysosomes. In the superficial 
uroepithelial cells, UPEC can break from those compartments into the cytosol and 
multiply rapidly to form biofilm-like intracellular bacterial communities. Within 
immature bladder epithelial cells which underlie the superficial epithelial cells, these 
apartments are often emeshed within a network of actin fibers and bacterial 
replication is greatly limited. It is suggested that UPEC could persist quiescently for 
long periods in these immature cells and could later lead to recurrent infections when 
induced to multiply (14).  
Upon UPEC infection, host tissues respond quickly by initiating various 
defense pathways. The presence of bacteria or bacterial products inside the normally 
sterile urinary tract could trigger rapid and robust responses from the host. The most 
obvious response after infection is the production of cytokines and influx of 
neutrophiles (64). Interactions between adherent UPEC and host epithelial cells 
stimulate the expression of a number of pro-inflammatory molecules, including 
interleukin 6 (IL-6), and IL-8, two cytokines found in the urine of patients with UTI. 
IL-6 is considered as a proinflammatory or immunomodulatory cykotine. It may 
facilitate the transition from a neutrophile to a predominantly monocytic response.  
IL-8, which serves as chemotactic stimuli, is a key components in aiding 
transepithelial migration of neutrophiles. Bladder epithelial cells play an important 
role in the innate immune response during a UTI, as they express Toll-like receptor 4 




secrete IL-6 and IL-8 in response to LPS and E. coli. Recently, UPEC have been 
found to be able to evade or subvert host innate immune response although the 
mechanism is not clear (6). It has been shown that UPEC can suppress NF-kB 
signaling pathway, which stimulates the transcription of anti-apoptotic and 
proinflammatory genes (36). Another prominent response of host is the exfoliation of 
infected epithelial cells. The bladder epithelium is normally quiescent and is only 
renewed every few months in healthy individuals. While soon after infection by 
UPEC, exfoliated epithelium cells could often be found with urine in UTI patients 
(48). Exfoliation of infected bladder cells containing intercellular bacterial 
communities may provide a means for the host to clear lots of bacteria with the flow 
of urine. However, this process also leaves the underlying layers of immature bladder 
epithelial cells exposed and more susceptible to UPEC infection. 
Treatment of E. coli infections 
Diarrhea caused by various diarrheagenic E. coli normally are self-limiting and do not 
require antibiotic treatment. For infants and children who are at high risk for 
dehydration, fluid replacement would be given in the case of fluid loss caused by 
ETEC, EPEC and EAEC. Antibiotics could also be given to those travelers who 
suffer from severe diarrhea to reduce the duration of the symptoms (35). But for 
infections caused by STEC, antibiotics are not recommended due to the potential risk 
of inducing more toxin production and making the disease worse (81). For severe 
HUS caused by STEC, compensation for possible kidney failure with dialysis is the 
current treatment strategy. In contrast to diarrheagenic infections, extraintestinal 




severe and potentially fatal infection such infant meningitis, are generally treated with 
antibiotics. Commonly prescribed antibiotics for extraintestinal infections include 
trimethoprim-sulfamethoxazole (TMP-SMX), fluoroquinolones, generations of 
cephalosporin and nitrofurantoin. Although antibiotics have been very useful in 
treating ExPEC infections in the past, the increase in antibiotic resistance in E. coli 
make treatment of E. coli infections complicated. For example, the emergence of 
fluoroquinolones resistant and extended-specturm beta-lactamse (ESBL) producing 
strains have caused great concern due to limited therapeutic options for infections 
with those E. coli strains (15, 47). Considering this situation, researche on developing 
effective vaccines and identifying risk factors for ExPEC infections are going on with 
an aim to prevent ExPEC infections (58). 
 
Detection methods 
Generally, detection of E. coli contamination in food samples is performed by pre-
enrichment and enrichment utilizing appropriate enrichment and selective media. 
Suspected isolates are subjected to a series of biochemical tests. Further 
characterization can be done by immunological methods to determine serotype and 
toxins. Specific cell cultures or animal models are used to assess their pathogenic 
potential. For example, the HEp-2 cell adherence assay is still the gold standard for 
detection of EAEC and DAEC. Although cell culture and animal models could 
provide direct evidence about the presence of pathogenic E. coli, most of them are 
time-consuming and require cumbersome work, especially when there are numerous 




models that can be used since some pathogenic E. coli can only cause disease in 
humans. Accumulating knowledge about genetic determinants that are responsible for 
E. coli pathogenesis makes molecular-based methods more and more popular in 
detecting and characterizing E. coli. Compared to phenotypic methods, molecular 
methods are generally more sensitive, quicker and easier for automation. Among all 
molecular methods, Polymerase Chain Reaction (PCR) is the most commonly used 
method to identify specific virulence genes in E. coli strains. PCR is especially 
advantageous when dealing with food samples, where a relatively low number of 
cells is present. The occurrence of real time PCR makes it possible for simultaneous 
quantification and detection of E. coli. Recently, great efforts have been taken to 
design methods which can examine a strain for all known E. coli virulence genes to 
assess its virulence potential (2, 39). Such broad range virulence gene detection 
systems, especially microarray system, would be very useful for differentiating 
pathogenic strains from non-pathogenic ones and identification of specific 
pathogroups. 
E. coli contamination in retail meat 
The intestinal tracts of food animals are natural habitats of different E. coli strains. 
Food products derived from these animals may be contaminated with E. coli during 
slaughter and further processing. E. coli contamination in retail meats has been found 
to be very common in various studies (42, 68).  Considering different pathogenic 
potential of different pathotypes of E. coli , most of these studies concentrated on 
O157 STEC, while other serogroups of STEC were not extensively assessed (24). 




strains in retail meats (11). Although meat is generally considered as vehicles to 
transmit diarrheagenic E. coli, recent researche showed that retail meat could be 
contaminated with various ExPEC strains and may represent an important means to 
disseminate ExPEC strains (28, 29). In addition, there was epidemiological evidence 
that meat consumption  was associated with urinary tract infection (45). Although the 
existence of ExPEC strains in meats was determined in some researche, those studies 
didn’t go further to assess the potential of those ExPEC from meat to cause disease 
such as urinary tract infections. 
Project overview 
Pathogenic E. coli can cause a wide variety of diseases in humans. There are many 
routes by which E. coli can be transmitted, including food and water, person-to-
person contact, and animal-to-person contact. Consumption of food (especially meats 
from food animals) contaminated with various DEC serves as a very common cause 
of human enteric infections with E. coli. In addition, researche suggests that foods 
might serve as a source of extraintestinal E. coli which are responsible for various 
extranitestinal infections. Those findings imply that ExPEC may represent an 
important group of foodborne pathogens. The goal of this study was to explore if E. 
coli from retail meat pose a significant human health threat as an important 
diarrheagenic pathogen as well as a potential source for ExPEC strains causing UTI. 
Three specific objectives of this project were as follows: 1) To detect and characterize 
different pathotypes of diarrheagenic E. coli in retail meats; 2) To determine the 
occurrence and antimicrobial resistance of  ExPEC in retail meats; and 3) To explore 




subsequent chapters (II to IV), three research studies are described that were 
performed to accomplish each objective respectively. 
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CHAPTER II.  PRESENCE AND CHARACTERIZATION OF 
SHIGA TOXIN-PRODUCING ESCHERICHIA COLI AND 





To determine the presence of Shiga toxin-producing Escherichia coli (STEC) 
and other potentially diarrheagenic E. coli in retail meats, 7,258 E. coli isolates 
collected by the U. S. National Antimicrobial Resistance Monitoring System 
(NARMS) retail meat program from 2002 to 2007 were screened for Shiga toxin 
genes.  In addition, 1,275 of the E. coli isolates recovered in 2006 were examined for 
virulence genes specific for other diarrheagenic E. coli. Seventeen isolates (16 from 
ground beef and 1 from pork chop) were positive for stx genes, including five for both 
stx1 and stx2, two for stx1 and 10 for stx2.  The 17 STEC belonged to 10 serotypes: 
O83:H8, O8:H16, O15:H16, O15:H17, O88:H38, ONT:H51, ONT:H2, ONT:H10, 
ONT:H7 and ONT:H46.  None of the STEC isolates contained eae, whereas seven 
carried EHEC-hlyA. All except one STEC isolate exhibited toxic effects on Vero 
cells. DNA sequence analysis showed that stx2 from five STEC isolates encoded 
mucus-activatable Stx2d. Subtyping of the 17 STEC isolates by PFGE yielded 14 
distinct restriction patterns.  Among the 1, 275 isolates from 2006, 11 atypical 




This study demonstrated that retail meats, mainly ground beef, were contaminated 
with diverse STEC strains. The presence of atypical EPEC strains in retail meat is 
also of concern due to their potential to cause human infections. 
Introduction 
Escherichia coli is an important component of the intestinal microflora of humans 
and warm-blooded mammals. While typically E. coli harmlessly colonize in the 
intestinal tract, several E. coli clones have evolved the ability to cause a variety of 
disease within the intestinal tract and elsewhere in the host. Those strains that cause 
enteric infections are generally called diarrheagenic E. coli, and their pathogenesis is 
associated with a number of virulence attributes that vary according to pathotypes 
(54). Currently, diarrheagenic E. coli is classified into six main pathotypes based on 
their distinct virulence determinants and pathogenic features, including: 
enteropathogenic E. coli (EPEC), enterotoxigenic E. coli (ETEC), enterohemorrhagic 
E. coli (EHEC)/ Shiga toxin-producing E. coli (STEC), enteroinvasive E. coli (EIEC), 
enteroaggregative E. coli (EAEC), and diffusively adherent E. coli (DAEC) (37). 
Among diarrheagenic E. coli, STEC are distinguished by their ability to cause 
severe life-threatening complications, such as hemolytic uremic syndrome (HUS) and 
thrombotic thrombocytopenic purpura (TTP) (30). Other symptoms of STEC 
infection include watery diarrhea, bloody diarrhea and hemorrhagic colitis (HC). 
STEC that cause HC and HUS are also called EHEC. Although individuals of all ages 
are at risk of STEC infection, children younger than five years and the elderly are 
more likely to experience severe complications (51). Outbreaks and sporadic cases of 




The pathogenesis of STEC infection in humans is not fully understood. The 
major virulence factors implicated in STEC infection are potent Shiga toxins, which 
are classified into two groups: Stx1 and Stx2 (23).  Additional factors that contribute 
to virulence have also been described, including intimin (encoded by eae gene), an 
outer membrane protein involved in the attachment of E. coli to the enterocyte, and 
EHEC-hemolysin (encoded by EHEC-hlyA), which acts as a pore-forming cytolysin 
and cause damage to cells (41). 
The first O157 STEC infections were reported in 1982 when E. coli O157:H7 
was involved in outbreaks associated with two fast food chain restaurants in the 
United States (44).  Since then, ever-increasing numbers of cases and outbreaks due 
to O157 STEC have been reported worldwide.  Although non-O157 STEC have also 
been associated with human cases and outbreaks, few laboratories have been looking 
for them and their potential in causing human infections may be underestimated (2). 
But recently, the significance of non-O157 STEC as human pathogens is becoming 
more recognized.  In the United States alone, there were 23 reported outbreaks of 
non-O157 STEC infection between 1990 and 2007 (10). 
Shiga toxin-producing E. coli can be transmitted through different routes, 
including food and water, person-to-person contact and animal-to-person contact (9). 
Most human infections are caused by consumption of contaminated foods (16). 
Domestic and wild ruminant animals, in particular cattle, are considered the main 
reservoir of STEC and the main source for contamination of the food supply.  Retail 
meats derived from animals could potentially act as transmission vehicles for STEC 




STEC contamination in retail meats; and fewer data exist about the presence of other 
diarrheagenic E. coli in retail meats. In the present study, we investigated 7,258 E. 
coli isolates from four types of meat samples (beef, chicken, pork and turkey) 
collected during 2002-2007 to assess STEC contamination in retail meats. In addition, 
the presence of other potentially diarrheagenic E. coli was examined by detecting 
specific virulence determinants among E. coli isolates collected in 2006. 
 
Materials and methods 
Bacterial strains.    A total of 7,258 E. coli isolates (1,806 from ground beef, 
2,106 from ground turkey, 2,179 from chicken breast, and 1,167 from pork chop) 
from the retail meat program of the U.S. National Antimicrobial Resistance 
Monitoring System (NARMS) were investigated. The detailed information of 
sampling, isolation, and identification could be found at 
http://www.fda.gov/AnimalVeterinary/SafetyHealth/AntimicrobialResistance/Nationa
lAntimicrobialResistanceMonitoringSystem/default.htm. Briefly, retail meats were 
collected monthly from grocery stores in four states (Georgia, Maryland, Oregon and 
Tennessee) from 2002 to 2007. For chicken and pork samples, one piece of meat was 
examined; for ground beef and ground turkey, 25 g of product was processed. 
Portions from each sample were placed in separate bags with 250 ml of buffered 
peptone water, and the bags were vigorously shaken. Fifty milliliters of the rinsate 
was mixed with 50 ml of double strength MacConkey broth and the content was 
incubated with shaking at 35°C for 24 h. One loop of the cultures was streaked onto 




was examined for typical E. coli colonies (colonies with a dark center and a green 
metallic sheen), and one typical, well-isolated colony was streaked onto a blood agar 
plate and incubated at 35°C for 24 h. Indole positive and oxidase negative isolates 
were presumptively identified as E. coli and confirmed as E. coli using the Vitek 2 
Compact microbial identification system (bioMérieux, Hazelwood, MO). All E. coli 
isolates were stored in Tryptic Soy Broth containing 15% glycerol at – 80°C until use. 
DNA template preparation.     E. coli were recovered from –80°C frozen 
culture and streaked onto blood agar plate and incubated overnight at 37°C. DNA of  
each isolate was extracted using boiling method previously described with 
modification (46). Briefly, approximately 10 to 20 colonies were taken by cotton 
swabs and were suspended in 500 µl distilled water. The mixture was then boiled at 
100°C for 10 min. After centrifugation at 18,000 × g for 5 min, supernatants were 
transferred to a new tube and stored in – 20°C until use in PCR amplification. 
Identification of Shiga toxin genes.     STEC were identified by the presence 
of stx1 and /or stx2 genes. All isolates were subjected to a multiplex PCR (assay 1) 
which targeted stx1 and stx2 and most of their variants (except stx1d and stx2f,, due to 
their considerable sequence divergence from classical stx1 and stx2, respectively) 
(Table II-1). PCRs were performed in a 25 µl reaction containing 2 µl of DNA 
template, 2.5 µl of 10×PCR buffer, 2 µl of a 1.25 mM mixture of deoxynucleoside 
triphosphate, 2.5 µl of 25 mM MgCl2, and 0.25 µl of 5 U of AmpliTaq Gold DNA 
polymerase (Applied Biosystems, Branchburg, NJ) and 0.5 µl (25 pmol) of each 
oligonucleotide primer (Invitrogen, Carlsbad, CA). Thermocycling protocol included 




°C for 30 s), annealing (58 °C for 30 s), and extension (72 °C for 30 s), and a final 
extension at 72 °C for 3 min. PCR products (10 µl) were resolved by electrophoresis 
with a 1.5% (wt/vol) agarose gel at 100mV for 30 min. Gels were then stained with 
ethidium bromide (0.5 µg /ml) and the DNA bands were visualized and photographed 
under UV illumination. E. coli EDL 933 containing stx1 and stx2 and K-12 were used 
as positive and negative control, respectively. For initial screening, DNA templates of 
five isolates were pooled and mixed thoroughly, and the mixture was used as template 
for PCR. When the mixture was tested positive for stx gene(s), DNA of individual 
isolates was then tested separately to identify stx positive isolate(s).  
DNA sequence and phylogenetic analysis of stx genes.    Shiga toxin genes 
were amplified and sequenced using primers listed in Table 1. The stx1 genes were 
amplified with primer Paton 1 to generate a 1,470 bp product which covered both A 
and B subunit of stx1. Two overlapping DNA fragments (779 and 714 bp), which 
together cover the entire stx2 gene, were amplified with primer sets Stx2-1 and Stx2-2, 
respectively. The PCR products were purified using 96-well multiscreen filter plates 
(Millipore Corp., Billerica, MA) and purified amplicons were sequenced on both 
strands. Sequencing reactions were performed using Big-dye terminator cycle 
sequencing ready reaction DNA sequencing kit and electrophoresed on AB3730 DNA 
sequencer (Applied Biosystems, Foster City, CA).  DNA sequence data were 
compiled and analyzed using DNA Sequencher 4.0 software (Gene Codes Corp., Ann 
Arbor, MI).  Nucleotide phylogenetic trees were generated by multiple sequence 
alignment and neighbor-joining analysis of the alignment using MAFFT program 




sequences for Shiga toxins were obtained from GenBank and indicated in the 
phylogenetic tree by their accession numbers. 
Vero cell cytotoxicity assay.     The STEC isolates were examined for their 
cytotoxicities on Vero cells according to the protocols published before (20, 55). 
First, 96-well microtitre plates were seeded with approximately 104 Vero cells/well 
and incubated at 37°C for 24 h in the presence of 5% CO2. The tissue culture medium 
(EMEM containing 10% fetal bovine serum; ATCC, Manassas, VA) was aspirated 
and replaced with 100 µl of fresh medium prior to the addition of bacterial 
supernatant dilutions. The bacterial isolates were inoculated into 5 ml LB broth and 
incubated overnight at 37°C with shaking. The cell concentration of the overnight 
bacterial culture was adjusted with LB broth to approximately 109 CFU/ml (OD600 = 
1). The culture was centrifuged at 10,000 × g for 10 min and the supernatant was 
filtered through a 0.45µm–pore-size membrane filter. The filtrate was serially diluted 
(1:5) in tissue culture medium. One hundred microliters of each dilution was 
inoculated to triplicate wells of the 96-well microtitre plate with Vero cells. Control 
wells, which refer to wells containing cells not inoculated with toxin, were included 
on each plate for untoxicated cell background. After incubation at 37°C in a 5% CO2 
atmosphere for 48 h, detached cells, medium and toxin were removed by vigorous 
shaking. Remaining Vero cells were fixed with 2% formalin in 0.067 M phosphate-
buffered saline (pH 7.2) for 1 min, the fixative was removed and the plate was stained 
with 0.13% crystal violet in 5% ethanol for 30 min. Excess stain was removed by 
rinsing, and the plates were air-dried. For quantification, stain was eluted with 200 µl 




microplate reader (Bio-Tek Instruments, Winooski, VT) at 600 nm wavelength. The 
color intensity was proportional to the number of viable, attached cells in the well. 
The absorbance values were then plotted against of the log of the toxin dilution. For 
determining the toxin dilution resulting in 50% cell detachment (CD50), the zero 
detachment dye absorbance value was obtained from control wells with untoxicated 
cell on each plate, and then CD50 value was determined by extrapolating one-half of 
this value to the log scale of toxin dilution. E. coli EDL933 and E. coli K-12 were 
used as positive and negative control, respectively. All assays were conducted in 
triplicate and independently repeated three times. 
eae and EHEC-hlyA genes.    The STEC isolates were further tested using a 
multiplex PCR (assay 4; Table 1) for the presence of eae and EHEC-hlyA genes.  
PCR conditions used were the same as described above. 
Genomic DNA fingerprinting using pulse-field gel electrophoresis 
(PFGE).    Genomic DNA fingerprints of the STEC isolates were further determined 
using PFGE according to a standard protocol developed by PulseNet for E. coli 
O157:H7 (19). Briefly, agarose-embedded DNA was digested with 50 U of XbaI for 
3h in a water bath at 37°C. DNA fragments were separated by electrophoresis in 
0.5×Tris-borate-EDTA buffer at 14°C for 18 h on a CHEF-III Mapper electrophoresis 
system with pulse time of 2.2 s to 54.2 s. The gels were stained with ethidium 
bromide (0.5 µg /ml) and images were taken under UV transillumination. The images 
were analyzed with Bionumerics Software by using Dice coefficients and unweighted 




Identification of virulence determinants of other diarrheagenic E. coli.    
To assess the presence of other potentially diarrheagenic E. coli in retail meats, 1,275 
E. coli isolates recovered from retail meats in 2006 were chosen and examined using 
two multiplex PCR (assays 2 and 3; Table 1), for detecting the following virulence 
gene markers: eaeA for intimin of EPEC, bfpA for the bundle-forming pilus of EPEC, 
elt and stI for heat labile and heat stable enterotoxins of ETEC, respectively, ial for 
invasion-associated locus of EIEC, aafII for aggregative adherence fimbriae II in 
EAEC, and daaE for F1845 fimbriae in DAEC. Each of the two PCR assays was 
performed in a 25 µl reaction mixture containing 2 µl of template DNA, 2.5 µl of 10 
× PCR buffer II, 2 µl of a 1.25 mM mixture of deoxynucleoside triphosphates, 4 µl of 
25 mM MgCl2, 0.25 µl of 5 U of AmpliTaq Gold DNA polymerase (Applied 
Biosystems, Branchburg, NJ), and 0.5µl (25 pmol) of each oligonucleotide primer 
(Invitrogen, Carlsbad, CA). The thermocycling conditions were as follows: 95°C for 
12 min, 94°C for 30 s, 60°C for 30 s, and 68°C for 3 min for 30 cycles, with a final 
10 min extension at 72°C. PCR products (10 µl) were examined with a 2% (wt/vol) 
agarose gel at 120 mV for 30 min. E. coli strains ATCC35401 (containing elt, stI), 
ATCC43893 (ipaH), ATCC43887 (eae, bfp), 042 (aafII), F1845 (daaE) were used as 
positive controls, while E. coli K-12 served as negative control. 
Serotyping.    All STEC and other potentially diarrheagenic E. coli isolates 
identified in the study were sent to E. coli Reference Center at Pennsylvania State 
University to determine their O antigen and H antigen. 
Nucleotide sequence accession numbers.     The nucleotide sequences of the 




N13844, N15018 were submitted to GenBank and given accession numbers 
GQ429154 to GQ429160. The nucleotide sequences of the complete stx2 operons 
from isolates N22813, 23765, N2688, N2743, N2746, N4854, N5545, N5578, 
N11354, N11355, N11682, N15432 and partial stx2 operon from N5789 were also 
deposited in the GenBank database under accession numbers GQ429161 to 
GQ429173. 
Statistical analysis.  Differences in percentage data were analyzed by Chi-
square test using SPSS software (Version 12.0, SPSS Inc. Chicago, IL). A P value of 




Presence of STEC in retail meats.    Among the 7,258 E. coli isolates 
recovered from retail meats collected in four states from 2002 to 2007, 17 (0.23%) E. 
coli were tested positive for the presence of stx gene(s) and considered as STEC 
(Table II-2). Almost all STEC isolates (n = 16) were from ground beef, accounting 
for 0.89% of 1,806 E. coli from this product. One STEC (0.09%) was identified 
among 1,167 E. coli from pork chop. No STEC was found in ground turkey or 
chicken breast. Five STEC were detected among 1,306 E. coli collected in 2005, 
followed by three STEC each in 2004, 2006 and 2007, two STEC in 2002 and one in 
2003.  The percentage of STEC among the E. coli isolates ranged from 0.08% to 
0.38% annually during the six-year period, but there is no significant difference in 




E. coli from Maryland, where a higher percentage (0.57%) of STEC was observed 
compared to other states (0.05-0.22%) (P < 0.05) 
Characterization of STEC.    Serotyping results showed that H antigens 
were successfully typed for all 17 STEC isolates, whereas O antigen of six STEC 
isolates could not be determined (Table II-2). Only five serotypes were found in 11 
typeable isolates. Many STEC isolates (7 out of 11) belonged to serotype O83:H8, 
whereas the other four typeable isolates exhibited different serotypes: O8:H16, 
O15:H16, O15:H27, O88:H38.  Different H types were observed in six O-
nontypeable isolates, among which isolates N5577 and N5578 reacted with the same 
H antiserum (H46).  
Digestion of genomic DNA from 17 STEC isolates with XbaI restriction 
enzyme and analysis using PFGE revealed 14 distinct profiles (Figure II-1). Although 
isolates of the same serotypes tended to cluster together, polymorphism of genome 
sequence was also observed between some isolates of the same serotype according to 
different PFGE patterns. Three pairs of STEC (N11354 and N11355, N2743 and 
N2746, and N11354 and N11355) showed identical PFGE profiles and serotypes. 
Isolates within each pair were recovered from the same food source (i.e. ground beef), 
and the same geographic locale.  Presumably they were the same clones.  All other 
isolates had their own specific PFGE profiles, with a similarity index ranging from 
67% to 84%. 
STEC virulence genes and Vero cell cytotoxicity.     Among the 17 STEC 
isolates, five contained both stx1 and stx2 genes, whereas two contained stx1 only and 




eae gene, while seven (41%) STEC isolates were EHEC-hlyA positive. Cytotoxicity 
of the STEC isolates was examined on Vero cells. Sixteen isolates were considered 
toxic to Vero cells when compared to E. coli K-12. Only one isolate (N5789) showed 
no cytotoxicity to Vero cells. For those cytotoxic STEC, their CD50 ranged from 10-1.2 
to 10-3.9 (Figure II-2).  Overall, STEC with both stx1 and stx2 displayed a greater 
toxicity (CD50 < 10-3.2) than those with only one of the stx genes, with the exception 
of N2743/N2746 and N13844.  
Stx gene sequence and phylogenetic analysis.    All stx1 genes from the 
seven STEC were successfully amplified and sequenced.  A portion of stx2 from 
N5789 could not be amplified despite  repeated efforts. In addition, chromatograms of 
stx2 sequences amplified from isolates N5577 and N15018 exhibited two peaks at 
several positions, suggesting the presence of more than one allele of stx2. Shiga toxin 
2 gene sequences from these two isolates were not further determined in this study 
and were excluded from phylogenetic analysis. Two previously described stx1 
sequences (one classical stx1 and one stx1c sequences), and seven stx1 sequences 
determined in this study, were aligned and used to construct a phylogenetic tree 
(Figure II-3a). Sequences were aligned from the start codon of stx1a to the stop codon 
of stx1b.  Most (6 out of 7) of the stx1 sequences in this study were closely related to 
the classical stx1, whereas stx1 from N15018 was very similar to stx1c. Isolates N2688 
and N13844 shared an identical stx1 gene sequence.  Isolates 22813, N11354 and 
N11355 also shared an identical stx1 gene sequence, but different from the stx1 gene 




Six previously described sequences of stx2 and its variants, and the 12 stx2 
sequences determined in this study were aligned (Figure II-3b). None of stx2 
sequences determined in this study were close to stx2e or stx2g (less than 93% 
similarity, data not shown).. Isolates 22813 and N11354 shared an identical stx2 gene 
sequence, as did N2743, N2746 and N11682.  Putative amino acid sequences analysis 
revealed that Stx from five isolates (N2743, N2746, N4854, N11682, N15432) 
possessed two amino acid substitutions Ser291 and Glu297 in Stx2 A2 subunit 
compared to classical Stx2 (data not shown), which were characteristic of mucus-
activatable Stx2d (Figure II-4). 
Presence of virulence genes specific for other diarrheagenic E. coli.    In addition 
to three STEC identified among the 1,275 E. coli isolates collected in the year of 
2006, 11 E. coli isolates were eat+/bfp- and were classified as atypical EPEC (Table 
II-2).  The positive rate of atypical EPEC in E. coli isolates from different types of 
meat were 1.2% in chicken breast (5/415), 1.4% in ground beef (4/293), 1.1% in pork 
chop (2/180) and 0% (0/387) in ground turkey. With the exception of three atypical 
EPEC isolates whose O serogroups could not be determined, none of the eight 
typeable EPEC isolates belonged to the same serotype (Table II-2). No virulence 







In this study, we analyzed 7,258 E. coli isolates recovered from retail meats 
collected by the NARMS program for the presence of stx genes and 1,275 E. coli 
isolates recovered in 2006 were further examined for virulence determinants of other 
dirreagenic E. coli.  To our knowledge, this was the largest survey of virulence 
factors in E. coli non-selectively recovered from retail meats.  Only a small number 
(17) of the E. coli were identified as STEC.  No DAEC, EIEC, and ETEC were 
detected in the 2006 collection of the E. coli isolates although 11 atypical EPEC were 
identified.   
Shiga toxin-producing E. coli are mostly commensal bacteria in animals with 
high potential for foodborne transmission to humans (9). Ruminants, primarily cattle, 
are the predominant reservoir of STEC and beef products serve as one of the most 
important sources for foodborne STEC infections (9). This consensus was supported 
by the result of present study that almost all STEC were recovered from ground beef. 
Contamination of STEC in beef has been examined by other researchers around the 
world. In the US, a recent study by Samadpour et al. reported STEC in 3.5%  of 1, 
750 retail ground beef samples collected from stores in Seattle, Washington (45). In 
other countries, STEC was detected in 4% of beef sample in France (43), and 3% of 
raw beef in Australia (11). Fantelli et al. reported STEC in 1.75% of minced beef in 
Switzerland (17) and Lee et al. found STEC in 1.5% of beef from Korea (32). Many 
factors, such as geographical locations, sampling, isolation and testing methods, make 
comparisons of different studies difficult. In a study using a similar protocol to ours, 




influence of regional difference or different processing technologies in other countries 
(32). Culture confirmation is also important factor affecting the results from different 
studies. In some papers, samples were considered to contain STEC only based on 
positive PCR results in enrichment broth (43, 45), while in other studies, culture 
confirmation was performed to assess the real occurrence of STEC in meat samples 
(6, 17). Such variations could lead to a big difference in results, since isolation of 
STEC from stx positive samples was found to be relatively difficult due to low 
number of bacterial cells or occurrence of free stx-carring phages in meat samples 
(43, 45). In terms of isolation method, instead of picking multiple colonies randomly 
from one plate and testing each of them (17, 26), colony hybridization with stx probe 
would more conveniently detect any STEC from all colonies on each plate and yield 
more accurate results (18, 45). The level of STEC contamination (< 1%) in the 
NARMS ground beef appeared low compared to reports from other investigators, but 
caution should be exercised in interpreting this low prevalence. The NARMS retail 
meat program was designed to determine the prevalence of generic E. coli, not STEC. 
Moreover, only one E. coli isolate was picked from each E. coli positive meat 
samples in NARMS meat program. Consequently, studies specifically designed to 
determine the prevalence of specific pathotypes such as STEC would likely detect a 
much greater prevalence. Nevertheless, screening over 7,000 randomly selected E. 
coli isolates from four states over a 6-year period provides useful data on the presence 
of STEC in retail meats against the background of generic E. coli populations.  
Moreover, the analysis of a large number of samples enables us to estimate the extent 




There is a paucity of data on the contamination of STEC in retail meats other 
than beef. In this study, only one STEC was found among 1,168 E. coli isolates from 
pork chop, whereas none of the E. coli from chicken (n = 2,181) and turkey (n = 
2,106) were identified as STEC. Swine was suggested to be a potential reservoir of 
STEC strains (18) and presence of STEC in pork has been reported before. In a study 
by Samadpour et al., 9 out of 51 pork samples collected in local grocery stores in 
Seattle area were positive of STEC (45). In New Zealand, Brooks et al. detected one 
STEC from 35 pork samples (6).  In contrast to swine, poultry is generally not 
considered to be a source of STEC. The lack of STEC in poultry meat from NARMS 
was consistent with the reports from Schroeder et al. who failed to detect STEC in 
retail chicken (51 ground chicken and 212 whole chickens) and turkey (50 ground 
turkey and 194 turkey breasts) samples from Washington D. C area (46).  Similarly, 
Brooks et al. failed to isolate STEC from 36 chicken samples in New Zealand (6, 46) 
and Heuvelink et al. did not find O157 STEC in raw chicken (n = 744) and poultry 
products (n = 75) in the Netherlands (26). However, Samadpour et al.  recovered  4 
STEC from  33 chicken breast and 1 from 15 turkey samples (12), and Doyle and 
Schoeni found O157 STEC in 4 of 263 poultry products (15). These isolations were 
previously thought to be possibly due to exposure to infected ruminants, but recent 
isolation of STEC from laying hens indicated that poultry may be a source of 
contamination (14). As discussed before, contamination rates in different studies 
could be affected by many factors, and attention needs to be paid when comparing 




Although O157:H7 is the most common STEC serotype that causes human 
illness in the U. S., there is growing concern over the emergence of highly virulent 
non-O157 STEC serotypes that are globally distributed, several of which are 
associated with outbreaks and/or severe human illness such as HUS and HC (2, 7). 
Although E. coli O157 was reported to be present in 0.7% of ground beef in a USDA 
study and 1.1% of beef in another study in Washington (38, 45), none of the STEC 
isolates in the present study belonged to serotype O157, which was in agreement with 
another study in the U. S. (50). Among the typeable STEC isolates, it is interesting to 
note the relatively common recovery of serotype O83:H8, which was not reported 
previously in food or animals. Although the seven isolates belonged to the same 
serotype, they did not have identical PFGE profiles and stx genotypes except N11354 
and N11355, indicating a non-clonal spread.  The fact that O83 STEC has been 
associated with human illness (2) raises the possibility that O83:H8 (with diverse 
genotypes and cytotoxicity) might transmit to humans via meat products. 
Additionally, isolate N15018 belonging to O15:H27, a serotype which has also been 
implicated in  human illness (42). Failure to determine O type for several STEC 
isolates suggests the complexity of STEC present in the retail meats. As many STEC 
isolates were non-typeable by seroptying, it is important to improve the current typing 
scheme, and to develop new typing technologies to encompass serogroups that are 
untypeable at present. 
Since not all STEC are equally pathogenic to humans, evaluation of virulence-
associated factors is necessary to assess an individual isolate’s potential to cause 




is consistent with findings of other studies in which no eae carriage was observed 
among non-O157 STEC from beef (24, 43). Studies have shown that most STEC 
from healthy cattle do not carry eae gene (22, 27), and since beef is generally derived 
from healthy cattle, this may explain the absence of eae in STEC from NARMS beef 
samples. Although eae is considered important to cause attaching and effacing lesion 
in human intestinal epithelial cells, it may not be essential for STEC pathogenicity 
since eae negative STEC have also been reported to cause severe human infections 
(39). It was postulated that eae-negative STEC may utilize additional adherence 
factors such as Saa (an autoagglutinating adhesin), Iha (an adherence-conferring 
protein), Efa1(an EHEC factor for adherence) and LP (the long polar fimbriae 
protein) in the disease process (52).  Interestingly, EHEC-hlyA gene was more 
frequently observed (41%, 7 out of 17) in the STEC isolates in the present study. 
Similar frequency (40-51%) of this gene was observed by Slanec et al. in STEC 
isolated from food samples (40%) and by Aidar-Ugrinovich et al. in STEC isolates 
from calves (51%) (1, 49). EHEC-hlyA is located in a large plasmid which many 
human pathogenic STEC strains often harbor. It may contribute to pathogenesis by 
acting as a pore-forming cytolysin on eukaryotic cells. The presence of this gene may 
enhance the virulence potential of those STEC isolates from retail meats. 
Shiga toxins differ in toxicity, toxin receptor, and amino acid sequences (33). 
Nucleotide sequences analysis of stx1 and stx2 present in our STEC isolates confirmed 
this finding. Stx2 gene sequences exhibited much more sequence diversity than did 
stx1 sequences (Figure 3). Three stx2 sequences were identical to a previously 




were identical to an stx2 allele in a bovine isolate (AY443054.1). No other stx2 
sequences were identical at the nucleotide level. All mucus-activatable stx2d 
sequences clustered together with two previously described activatable stx2d (stx2d1 
and stx2d2) but with some sequence difference (Figure 3b). Stx2c and stx2 from N5545 
were also included in the cluster but they did not have the characteristic amino acid 
substitutions common in activatable stx2d. There are two isolates (N5577, N15018) 
whose stx2 chromatograms showed two peaks at multiple sites, which indicates that 
these two strains may carry more than one allele, an interesting phenomenon that was 
also observed by other researchers (3). All STEC isolates were shown to be toxic to 
Vero cells except one isolate (N5789). The stx2 sequence could not be obtained for 
this isolate since it could not be amplified by the first pair of sequence primers. 
Several primers were tried to amplify a fragment which would cover the stx2A 
subunit of the gene, but part of stx2A could never be amplified. It is possible that a 
large intervening insertion may be present that prevents successful PCR 
amplification. It is also possible that this insertion abolishes the activity of Stx2A and 
consequently renders the isolate less toxic compared to other STEC.  
Shiga toxin types were suggested to correlate with the clinical symptoms of 
STEC infection (28).  Mucus-activatable Stx2d was associated with high virulence 
and ability to cause HUS (4, 21, 28). The particular attribute of this variant is that it 
could be cleaved by elastase in the intestinal mucosa causing an increase in 
cytotoxicity up to 1,000-fold (31). This character is attributed to two amino acid 
substitutions relative to the sequence of classical Stx2, Ser291 and Glu297. Based on 




study harbored mucus-activatable stx2d. The relatively high number of mucus-
activatable stx2d found in STEC isolated from retail meat deserves attention. Studies 
found that eae negative, mucus-activatable Stx2d producing STEC were involved in 
sporadic and outbreak cases of HC and HUS (28, 40). It was also shown that although 
eae negative STEC are normally isolated from persons with no or mild disease, most 
eae negative STEC associated with severe symptoms harbor mucus-activatable stx2d  
as the sole stx gene (4). The pathogenic potential of the five isolates with mucus-
activatable stx2d should not be underestimated. Currently very limited data are 
available concerning the presence of STEC strains harboring mucus-activatable stx2d 
in food or livestock source. Zheng et al. identified seven STEC carrying activatable 
stx2d  in 153 STEC strains isolated from food, cattle and human, none of them contain 
eae gene (55). Gobius et al. investigated 311 STEC possessing stx2 from food and live 
stock and found 12 STEC carrying activatable stx2d, all of which did not have eae 
either (21). It has been suggested that the expression of an activatable toxin may 
compensate for the lack of intimin (34). Due to their strong association with severe 
clinical outcomes, more surveillance of STEC strains expressing activatable stx2d in 
food and human illness are warranted. 
Another interesting finding of this study was the identification of several 
atypical EPEC. EPEC is a leading cause of infant diarrhea in developing countries 
and also an important cause of diarrhea in developed countries (53). Typical EPEC 
contain both eae and bfp, while atypical EPEC contain only eae. In industrialized 
countries, typical EPEC infections have decreased and atypical E. coli seems to have 




humans, atypical EPEC have been isolated from a variety of animal species such as 
cattle, goats, sheep, chickens, pigeons and gulls (13). In addition to chicken and beef, 
we also identified atypical EPEC among E. coli isolates from pork, indicating pigs 
may also be potential reservoirs for the pathogen. Atypical EPEC found in this study 
belonged to a variety of serogroups, most of which were not found in atypical EPEC 
involved in human infections. However, isolate N11573 belonged to O26, a 
serogroup that is frequently found in classic human EPEC strains (8). Further studies 
are needed to determine whether atypical EPEC of animal origin could actually cause 
human infections when ingested.  
In conclusion, retail meats, especially ground beef, were contaminated with 
STEC, although at a very low frequency, and some of the strains contained Shiga 
toxins associated with high potential to cause severe human disease. Moreover, the 
identification of atypical EPEC strains in retail meats is noteworthy, and the potential 
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Table II - 1. Oligonucleotide primers used in multiplex PCR and sequencing. 




Assay 1 stx1 GTGGCATTAATACTGAATTGTCATCA    GCGTAATCCCACGGACTCTTC 109 (29)
 stx2 GGCACTGTCTGAAACTGCTCC    
    
    
    
    
    
   
    
    
TCGCCAGTTATCTGACATTCTG 255 (47)
Assay 2 stI TCTTTCCCCTCTTTTAGTCAGTC CAGCACAGGCAGGATTAC 170 (36)
 elt ACGGCGTTACTATCCTCTC TGGTCTCGGTCAGATATGTG 274 (48)
 daaE GAACGTTGGTTAATGTGG GGTAA TATTCACCGGTCGGT TATCAGT 542 (54) 
 aafII CACAGGCAACTGAAA TAAGTCTGG ATTCCCATGATGTCA AGCACTTC 378 (54)
Assay 3 eae* CTGAACCAGATCGTAACGGC TGATAAGCTGCAGTCGAATCC 229 (36)
 bfpA AACCGTTACTGCCGGTGTGA GTTGCCGCCTCAGCAGGAGT 450 (36)
 ipaH CTCGGCACGTTTTAA TAGTCTGG GTGGAGAGCTGAAGTTTCTCTGC 933 (54)








    
    
    
     
    
Stx1 sequencing Paton 1 TCGCATGAGATCTGACC AACTGACTGAATTGAGATG- 1, 470 (5) 
Paton 2  ATAAATCGCCATTCGTTGACTAC AGAACGCCCACTGAGATCATC 180 (5)
Gannon ACACTGGATGATCTCAGTGG CTGAATCCCCCTCCATTATG 603 (5)
Vidiya TCGCATGAGATCTGACC AATAAGCCGTAGATTATT 448 (5)
Stx2 sequencing Stx2-1 TTCTGAGCAATCGGTCACTG CGGCGTCATCGTATACACAG 779 (55)





        
 
 
Table II - 2. Characteristics of Shiga toxin-producing E. coli (STEC) and atypical 
enteropathogenic E. coli (EPEC) isolates from retail meats.a 
 
 
ID  Serotype stx1 stx2 eae/eaeA EHEC- hlyA bfp Source State Year
22813 O83:H8 + + - +  Ground beef MD 2002
N2688 O88:H38 + + - +  Ground beef MD 2004
N11354 O83:H8 + + - +  Ground beef GA 2006
N11355 O83:H8 + + - +  Ground beef GA 2006
N15018 O15:H27 + + - -  Ground beef GA 2007
20177 O8:H16 + - - -  Ground beef TN 2002
N13844 ONT:H51 + - - -  Pork chop OR 2007
N5577 ONT:H46 - + - +  Ground beef MD 2005
N5578 ONT:H46 - + - +  Ground beef MD 2005
N5789b O15:H16 - + - +  Ground beef MD 2005
23765 ONT:H2 - + - -  Ground beef OR 2003
N2743 O83:H8 - + - -  Ground beef MD 2004
N2746 O83:H8 － + - -  Ground beef MD 2004
N4854 ONT:H10 － + - -  Ground beef MD 2005
N5545 ONT:H7 － + - -  Ground beef MD 2005
N11682 O83:H8 - + - -  Ground beef MD 2006
N15432 O83:H8 - + - -  Ground beef OR 2007
N11475 O154:H9   +  - Chicken breast GA 2006






N11573 O26:H9   +  - Chicken breast GA 2006
N11575 O123:H51   +  - Chicken breast GA 2006
N12563 ONT:H7   +  - Chicken breast TN 2006
N11452 ONT:H8   +  - Ground beef GA 2006
N12148 ONT:H8   +  - Ground beef OR 2006
N12174 O15:H2   +  - Ground beef OR 2006
N12475 O10:H2   +  - Ground beef TN 2006
N11710 O18:H16   +  - Pork chop MD 2006
N12051 O81:H7   +  - Pork chop OR 2006
a Common virulence genes include stx1 and stx2, eae and EHEC- hlyA for STEC; and eaeA and 
bfp for EPEC. 
b This strain was negative for vero cell cytotoxicity assay, but whether it could produce Stx or not 




pt:1.50%) (Tol 1.5%-1.5%) (H>0.0% S>0.0%) [0.0%-98.3%]
PFGE-XbaI
Figure II - 1. Dendrogram of PFGE profiles with XbaI for 17 STEC isolates from retail meat.  











Strains     Serotype Source State Year
N11354     O83:H8 Ground beef GA 2006
N11355     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
O83:H8 Ground beef GA 2006
22813 O83:H8 Ground beef MD 2002
N15432 O83:H8 Ground beef OR 2007
N2743 O83:H8 Ground beef MD 2004
N2746 O83:H8 Ground beef MD 2004
N11682 O83:H8 Ground beef MD 2006
N13844 ONT:H51 Pork chop OR 2007
N5789 O15:H16 Ground beef MD 2005
23765 ONT:H2 Ground beef OR 2003
N15018 O15:H27 Ground beef GA 2007
N4854 ONT:H10 Ground beef MD 2005
N5545 ONT:H7 Ground beef MD 2005
20177 O8:H16 Ground beef TN 2002
N5577 ONT:H46 Ground beef MD 2005
N5578 ONT:H46 Ground beef MD 2005
N2688 O88:H38 Ground beef MD 2004
 
Figure II - 2. Vero cell cytotoxicity of Shiga toxin producing E. coli isolates from retail 
meats.  
CD50 is expressed here as the toxin dilution that causes 50% Vero cells detachment 
compared with untreated cells (control).  The value on Y axis indicates the log of the 
reciprocal of CD50. The data shown are the average of three independent assays. 





















































































Figure II - 3. Phylogenetic trees of stx1 sequences (A) and stx2 sequences (B) determined 
in this study and sequences of previously described stx genes and their variants.  
Stx1d and stx2f were not included due to their considerable sequence divergence from 
classical stx1 and stx2, respectively. The horizontal bar indicates 0.001 (in A) and 0.002 
(in B) nucleotide substitutions per site. Reference DNA sequences for stx genes were 
obtained from GenBank and identified in the phylogenetic trees by their accession 
numbers. 
 




























Figure II - 4. Multiple sequence alignment of predicted amino acid sequences of A 
subunit from five Shiga toxin 2 (Stx2) variants determined in this study with the 
previously published Stx2d1and Stx2d2 (both activatable) and classical Stx2.  





Stx2d1    1 MKCILFKWVLCLLLGFSSVSYSREFTIDFSTQQSYVSSLNTIRTEISTPLEHISQGTTSV 
N4854     1 ............................................................ 
Stx2d2    1 ........................................S................... 
N15432    1 ........................................S................... 
N11682    1 .....L..................................S................... 
N2743     1 .....L..................................S................... 
N2746     1 .....L..................................S................... 
Stx2      1 ........................................S................... 
 
Stx2d1   61 SVINHTPPGSYFAVDIRGLDVYQARFDHLRLIIEQNNLYVAGFVNTATNTFYRFSDFTHI 
N4854    61 ............................................................ 
Stx2d2   61 ............................................................ 
N15432   61 ............................................................ 
N11682   61 ............................................................ 
N2743    61 ............................................................ 
N2746    61 ............................................................ 
Stx2     61 ............................................................ 
 
Stx2d1  121 SVPGVTTVSMTTDSSYTTLQRVAALERSGMQISRHSLVSSYLALMEFSGNTMTRDASRAV 
N4854   121 ............................................................ 
Stx2d2  121 ............................................................ 
N15432  121 ............................................................ 
N11682  121 ............................................................ 
N2743   121 ............................................................ 
N2746   121 ............................................................ 
Stx2    121 ............................................................ 
 
Stx2d1  181 LRFVTVTAEALRFRQIQREFRQALSETAPVYTMTPGDVDLTLNWGRISNVLPEYRGEDGV 
N4854   181 ............................................................ 
Stx2d2  181 ............................................................ 
N15432  181 ............................................................ 
N11682  181 ............................................................ 
N2743   181 ............................................................ 
N2746   181 ............................................................ 
Stx2    181 ............................................................ 
 
Stx2d1  241 RVGRISFNNISAILGTVAVILNCHHQGARSVRAVNEESQPECQITGDRPVIKINNTLWES 
N4854   241 ............................................................ 
Stx2d2  241 ............................................................ 
N15432  241 ............................................................ 
N11682  241 ............................................................ 
N2743   241 ............................................................ 
N2746   241 ............................................................ 
Stx2    241 ............................................................ 
 
Stx2d1  301 NTAAAFLNRKSQSLYTTGE 
N4854   301 ................... 
Stx2d2  301 ................... 
N15432  301 ................... 
N11682  301 ................... 
N2743   301 ................... 
N2746   301 ................... 
Stx2    301 ............F.....K 
 
 





CHAPTER III.  IDENTIFICATION AND ANTIMICROBIAL 
RESISTANCE OF EXTRAINTESTINAL PATHOGENIC 
ESCHERICHIA COLI FROM RETAIL MEAT 
 
Abstract 
Extraintestinal pathogenic Escherichia coli (ExPEC) cause a variety of infections 
outside the gastrointestinal tract. Retail meats are frequently contaminated with E. coli 
strains and might serve as a vehicle for transmitting ExPEC. A total of 1,275 E. coli 
isolates recovered from ground beef, ground turkey, chicken breast and pork chop 
obtained in Georgia, Maryland, Oregon and Tennessee of the United States in 2006 were 
investigated for the presence of ExPEC using multiplex PCR. Identified ExPEC isolates 
were assigned to serogroups and phylogenetic groups, and analyzed for antimicrobial 
susceptibility. Approximately 16% (200/1,275) of the E. coli isolates were identified as 
ExPEC based on defined genetic criteria. The occurrence of ExPEC was the highest in E. 
coli isolated from ground turkey (23.5%) and chicken breast (20.2%), but less in E. coli 
from pork chop (8.3%) and ground beef (3.4%).  Phylogenetic grouping revealed that 
most ExPEC isolates (66.5%) fell into the same phylogenetic groups (B2 and D) as 
virulent human ExPEC strains.  Among the 15 antimicrobial agents tested, resistance to 
tetracycline (67.0%), sulfisoxazole (59.5%) and streptomycin (46.0%) was most frequent.  
Most ExPEC isolates (n = 163, 81.5%) were resistant to at least one antimicrobial, and 
more than half (n = 114, 57%) exhibited resistance to at least three drugs. Our findings 




retail meats, especially in chicken and turkey products. These findings indicate a need to 
better understand the potential role of foods as a source of human ExPEC infection. 
 
Introduction 
Escherichia coli are prominent for their versatility in causing disease. In addition to 
gastrointestinal infections typically presented as diarrhea, it also causes a variety of 
diseases outside of the intestinal tract of humans and animals (22). Typical extraintestinal 
infections caused by E. coli include urinary tract infections (UTI), meningitis, sepsis, 
abdominal infections, osteomyelitis, cellulitis, and wound infections (17). E. coli 
pathotypes that cause extraintestinal infections are collectively called extraintestinal 
pathogenic E. coli (ExPEC) (32). Although ExPEC are not as well-known as 
diarrheagenic E. coli, they cause about 6.7-8.6 million cases of human infections with 
estimated annual medical costs of $1.5-2.3 billion dollars in the United States (31). 
             ExPEC are phylogenetically and epidemiologically distinct from commensal and 
diarrheagenic E. coli.  In contrast to commensal strains, which mainly derive from 
phylogenetic groups A and B1 and lack virulence traits, most ExPEC belong to 
phylogenetic groups B2 and D and harbor various virulence-associated factors that allow 
them to induce diseases in both healthy and compromised hosts (18). Typical virulence 
factors in ExPEC include diverse adhesins, siderophores, capsules, toxins, proteases, 
invasins, and serum resistance proteins (18). Most of these virulence factors are distinct 
from those found in diarrheagenic E. coli. These determinants may be arrayed in different 




             In spite of the fact that ExPEC impose a great economical and medical burden on 
society, they have long been underappreciated.  This is partly due to the sporadic nature 
of ExPEC infections compared to diarrheagenic E. coli, which are often involved in 
common source outbreaks (17). Many aspects of ExPEC infections, such as source and 
transmission pathways, remain largely undetermined. Animal-derived foods are 
commonly contaminated with E. coli and have long been known as an important vehicle 
for transmitting diarrheagenic E. coli (8, 27), but their role in spreading ExPEC has not 
been extensively explored. Recent studies indicated that retail meats were contaminated 
with ExPEC strains that share characteristics with clinical ExPEC (7, 10, 12).  In 
addition, it was suggested that meat consumption was epidemiologically associated with 
antimicrobial-resistant E. coli causing UTI (23, 29).  These findings indicate that meat 
may represent a possible reservoir and/or transmission vehicle of ExPEC.  With the aim 
to gain a better understanding of extraintestinal pathogenic potential of meat-derived E. 
coli, we investigated 1,275 E. coli strains isolated from retail meats acquired over a year 
of testing (2006) in four states to determine the prevalence of E. coli strains carrying 
virulence genes associated with human ExPEC infections, and to investigate those 
potentially pathogenic strains for serotype, phylogenetic group and antimicrobial 
susceptibility profiles.  
 
 
Materials and methods 
Retail meat sampling and bacterial strains. E. coli were recovered from meat samples 




meat program in local grocery stores in Georgia, Maryland, Oregon and Tennessee from 
January to December 2006.  Detailed information on sampling, isolation, and 
identification can be found at http://www.fda.gov/AnimalVeterinary/SafetyHealth/ 
AntimicrobialResistance/NationalAntimicrobialResistanceMonitoringSystem/default.htm
. NARMS testing recovered a total of 1, 275 E. coli isolates: 180 from pork chop, 387 
from ground turkey, 293 from ground beef and 415 from chicken breast that were used in 
this study.  Two clinical ExPEC strains, E. coli V27 and 2H16, kindly provided by Dr. 
James R. Johnson (University of Minnesota, Minneapolis, MN), were used as control 
organisms. All bacteria were kept at –80 °C in brain heart infusion broth with 20% 
glycerol until use. ExPEC isolates were sent to E. coli Reference Center at Pennsylvania 
State University to determine O antigens employing all available O (O1 to O185) 
antisera. 
Antimicrobial susceptibility testing. Antimicrobial minimum inhibition 
concentrations (MICs) were determined by FDA-CVM using the Sensititre automated 
antimicrobial susceptibility system (Trek Diagnostic Systems, Cleveland, Ohio) and 
interpreted according to the Clinical  and Laboratory Standards Institute (CLSI) 
guidelines for broth microdilution methods (2, 3). The antimicrobials tested, and the 
resistance breakpoint used, were as followed: amikacin (≥64 µg/ml), amoxicillin-
clavulanic acid (≥32/16 µg /ml), ampicillin (≥32 µg/ml), cefoxitin (≥32 µg/ml), ceftiofur 
(≥8 µg/ml), ceftriaxone (≥4 µg/ml), chloramphenicol (≥32 µg/ml), ciprofloxacin (≥4 
µg/ml), gentamicin (≥16 µg/ml), kanamycin (≥64 µg/ml), nalidixic acid (≥32 µg/ml), 
streptomycin (≥64 µg/ml), sulfisoxazole (≥512 µg/ml), tetracycline (≥16 µg/ml), and 




35218, Enterococcus faecalis ATCC 29212, Staphylococcus aureus ATCC 29213, and 
Pseudomonas aeruginosa ATCC 27853 were used as controls in antimicrobial MIC 
determinations. 
ExPEC virulence genotyping. The E. coli isolates were tested using a multiplex 
PCR for the following virulence associated markers: papA (P fimbriae structural subunit) 
and/or papC (P fimbriae assembly), sfa/foc (S and F1C fimbriae subunits), afa/dra (Dr-
antigen-binding adhesins), kpsMT II (group 2 capsular polysaccharide units), and iutA 
(aerobactin receptor) (Table III-1). ExPEC was defined as E. coli containing two or more 
of the five virulence genes (papA and papC were analyzed collectively) (16). DNA of E. 
coli isolates were extracted using boiling methods (33). PCR was performed in a 25 µl 
reaction mixture containing 2 µl of template DNA, 2.5 µl of 10 × PCR buffer II, 2 µl of a 
1.25 mM mixture of deoxynucleoside triphosphates, 4 µl of 25 mM MgCl2, 0.25 µl of 5 
U of AmpliTaq Gold DNA polymerase (Perkin-Elmer, Foster City, CA), and a 0.6 µM 
concentration of each primer (Invitrogen, Carlsbad, CA). The thermocycling conditions 
were as follows: 95°C for 12 min, 94°C for 30 s, 60°C for 30 s, and 68°C for 3 min for 30 
cycles, with a final 10 min extension at 72°C. PCR products (10 µl) were evaluated with 
a 2 % (wt/vol) agarose gel at 120 mV for 30 min. A molecular marker (100 bp DNA 
ladder; New England BioLabs, Ipswich, MA) was run concurrently. The DNA mixture of 
two clinical strains (V27 and 2H16,) which together harbored all of the virulence genes 
tested, was used as a positive control, whereas the DNA of E. coli K-12 served as a 
negative control. 
Phylogenetic grouping. ExPEC isolates were subjected to phylogenetic 




and DNA fragment TspE4.C2, were amplified using primers in Table III-1. The PCR was 
performed under the following conditions: 94°C for 4 min, 30 cycles of 94°C for 5 s, 
59°C for 10 s, and a final 5 min extension at 72°C. The results of amplification were 
analyzed to assign the isolates to one of four phylogenetic groups according to the 
following criteria: E. coli negative of both chuA and TspE4.C2 were assigned to group A; 
E. coli negative of chuA but positive of TspE4.C2 to group B1; E. coli positive of both 
chuA and yjaA to group B2; E. coli positive of chuA but negative of yjaA to group D (4). 
Statistical analyses. Comparisons of proportions for a characteristic in different 
groups were tested by Chi-square test. The threshold for significance was P < 0.01. All 




                Presence of ExPEC and virulence markers in E. coli isolates from retail 
meats. ExPEC was defined by the presence of at least two of the five virulence markers 
tested. Two hundred (15.7%) E. coli isolates met the criteria and were considered as 
ExPEC. The occurrence of ExPEC varied in E. coli isolates from different meat types, 
with the highest rate in E. coli from ground turkey (23.5%) and chicken breast (20.2%), 
followed by those from pork chop (8.3%), and ground beef (3.4%) (Table III-2).  
                Among the 1,275 E. coli isolates, iutA was most frequently present and 
detected in 63.1 % of E. coli isolated from chicken, and 53%, 18.3% and 8.5% of E. coli 
from ground turkey, pork chop and ground beef, respectively.  The kpsMT II locus 




from pork and turkey, respectively, but not in E. coli from beef and chicken.  papA and 
papC were in 0.7-2.8% and 2.4-13.7% of E. coli from different meats, respectively. None 
of the E. coli isolates carried afa/dra gene (Table III-2).  
                Serotyping. Determining O-antigen for the 200 ExPEC isolates revealed that 
they belonged to a variety of serogroups. One hundred and sixty-seven isolates were O-
antigen typeable, including six isolates that reacted with two antisera.  The remaining 33 
ExPEC isolates were non-typeable using currently available antisera (Table III-3). There 
were 42 different serogroups among 167 typeable ExPEC isolates. The most common 
serogroup was O2 (20.5 %), followed by O25 (9.5 %) and O11 (5 %). The remaining E. 
coli isolates were scattered among 39 other serogroups, with less than 10 isolates per 
serogroup. More than half  (55%) of all typeable isolates fell into serogroups commonly 
associated with E. coli causing urinary tract infection (O1, O2, O4, O6, O7, O8, O16, 
O18, O25, O75). Serogroup O25 (17.9%) was most common for isolates from chicken, 
whereas O2 (36.2%) was most frequently identified in ExPEC from turkey (Table III-3). 
                Phylogenetic grouping.  E. coli can be classified into four major phylogenetic 
groups: A, B1, B2 and D. In general, most human ExPEC clinical isolates belong to 
group B2 or D. PCR-based phylogenetic analysis showed that 133/200 (66.5%) of the 
ExPEC isolates from retail meat fell into groups B2 (42.0%) or D (24.5%), followed by 
group A (22.5%) and group B1 (11.0%) (Table III-4).  ExPEC from chicken breast were 
relatively evenly distributed in groups B2/D (55.9% of isolates) and in group A/B1 
(44.1%).  A large proportion of isolates from ground turkey (79.1%) and ground beef 
(90%) were assigned to groups B2 and D.  More than half of ExPEC (66.7 %) from 




Combining data for serogrouping revealed that 87.8% of O2 strains and all of 
O25 strains fell into phylogenetic B2 group, while 60% of O11 isolates belonged to 
group D. Non-typeable strains and the remaining uncommon isolates were evenly 
distributed in different phylogenetic groups (data not shown). 
                 Distribution of virulence genes among strain subtypes. Among all virulence 
associated factors tested, papC was significantly positively associated with phylogenetic 
group B1 and negatively associated with B2, while kpsMT II was negatively associated 
with group B1 and A and positively associated with group B2 (Table III-5). Others 
virulence genes were widely dispersed and were not significantly associated with any 
phylogenetic group. According to resistance status, papC occurred more frequently in 
resistant isolates than susceptible isolates, while other genes were equally distributed in 
resistant and susceptible isolates (Table III-5).          
                Antimicrobial resistance.  Analysis of antimicrobial resistance data from 
FDA-CVM  revealed that most ExPEC isolates (163/200) exhibited resistance to at least 
one of the 15 antimicrobials tested and considered as resistant isolates (Figure III-1). The 
highest resistance was to tetracycline (67%), and followed by resistance to sulfisoxazole 
(59.5%) and streptomycin (46%). A lower level of resistance was found to antimicrobials 
such as gentamicin (31.5%), kanamycin (28%), ampicillin (22.5%) and nalidixic acid 
(10.5%), (Figure III-1). All ExPEC isolates were susceptible to ciprofloxacin, with the 
exception of one ExPEC from turkey, which was resistant to ciprofloxacin and 11 
additional antimicrobials. Ten ExPEC isolates, including 7 (8.3%) from chicken, 2 (20%) 




(using the new CLSI resistance breakpoint; see ref. 3).  All isolates were susceptible to 
amikacin.  
                More than half (114/200) of the ExPEC isolates were resistant to at least three 
antimicrobials, and nine isolates showed resistance to more than eight antimicrobials 
(data not shown). Three ExPEC isolates from chicken breast, two of which belonged to 
the same serogroup and phylogenetic group, shared the same multi-drug resistance 
(MDR) pattern for nine antimicrobials: amoxicillin-clavulanic acid, ampicillin, cefoxitin, 
ceftiofur, ceftriaxone, kanamycin, streptomycin, sulfisoxazole and tetracycline. Two 
isolates, one from ground turkey and one from ground beef were resistant to 12 
antimicrobials.  The turkey isolate was only susceptible to amikacin, ceftiofur and 
ceftriaxone, while the beef isolate was susceptible to amikacin, chloramphenicol and 
ciprofloxacin. There were no significant associations between antimicrobial resistance 




Foods are a main vehicle for transmitting enteric zoonotic pathogens, most notably E. 
coli O157:H7, Campylobacter and Salmonella (5, 24).  More recent data imply a 
potential role of foods, particularly raw retail meats, as vehicles for transmitting fecal 
pathogens capable of causing extraintestinal infections (10, 12, 16, 23, 36). In this study, 
we analyzed 1,275 E. coli isolates recovered from four different meat products from 
January to December 2006 for their ExPEC virulence markers, phylogenetic background, 




testing in this study were obtained by selecting a single colony from the culture plate.  
We made no attempt to enrich for Shiga toxin-producing E. coli strains, nor to capture the 
diversity of E. coli within a given meat sample. With this approach, 200/1,275 retail meat 
strains were classified as ExPEC based on molecular criteria.  Moreover, many of these 
meat-derived ExPEC belonged to phylogenetic clusters and serogroups commonly 
associated with strains causing human clinical illness. In addition, antimicrobial 
resistance was common among isolates carrying virulence determinants. These findings 
support the hypothesis that food animals may be a reservoir, and retail meats may be a 
vehicle, for transmitting human pathogenic E. coli causing extraintestinal infections, 
including strains that are resistant to antimicrobials.  
ExPEC were much more common in poultry (20.2-23.5%) than ground beef 
(8.3%) and pork chop (3.4%), which is consistent with previous studies (10, 12) where 
more than one CFU/sample was selected for testing.  A similar prevalence (20-22%) of 
ExPEC was reported in E. coli isolated from poultry products in Minnesota and 
Wisconsin, and among subsets of NARMS meat isolates (14, 16, 19). These comparable 
data observed in studies investigating foods from different areas and time periods 
supports a poultry meat baseline level of 18-25% for strains defined as ExPEC by these 
specific criteria.  Poultry has long been considered as a source of E. coli strains with 
zoonotic potential (6, 21, 25, 30). Certain avian pathogenic E. coli (APEC), which can 
cause lethality in mice and exhibit pathogenic traits in vivo (9, 34), also share many 
virulence traits with human ExPEC (6, 21, 25, 30) . Bonnet et al. reported that 75% of 
ExPEC from poultry in Canada (defined using the same criteria as this study) also could 




retail poultry meat contained virulence genes that typify APEC (20). While we did not 
attempt to determine the carriage of APEC-specific factors in this study, our observation 
that ExPEC are common in poultry products is consistent with these findings in 
supporting retail meats as a source of pathogenic E. coli capable of infecting both birds 
and humans.   
The strains of ExPEC found in retail meats shared other characteristics with 
human clinical ExPEC isolates. A considerable proportion of meat-derived ExPEC were 
from O serogroups commonly associated with E. coli causing UTI in humans (37), such 
as serogroups O1, O2, O4, O6, O7, O8, O18, O25. Notably, O2 was the most common O- 
antigen found in ExPEC isolated from retail meat. All isolates in this serogroup belonged 
to virulent phylogenetic groups, either group B2 (88%) or group D (12%), which may 
explain frequent occurrence of this serogroup in strains encountered in animal and human 
infections (6, 25). The second most common serogroup, O25, appeared exclusively 
among phylogenetic group B2. O25 has also been associated with strains causing disease 
in humans and animals (15, 26).  Several ExPEC strains from retail meat were O11 and 
O73, which belong to a cluster or serogroups (typically from O11/O17/O73/O77), which 
were responsible for clusters of UTIs in the U.S. and other countries (13, 29).  Thus, in 
addition to ExPEC genotypes, serogroups also overlapped with those associated with 
human extraintestinal infections. 
An epidemiological link between frequent chicken or pork consumption and 
community-acquired urinary tract infections has been demonstrated, which implicated a 
foodborne  route for strains causing UTI (23). A recent study by Vincent et al. further lent 




human UTI strains (36). Our finding of many meat-source ExPEC strains from UTI-
associated serogroups may indicate their uropathogenic potential and also support 
possible food reservoir of human UTI-associated strains. In addition, a large proportion 
(86%) of isolates from UTI-associated serogroups were derived from chicken or turkey, 
suggesting that a poultry foodborne pathway is more likely in transmitting UTI-causing 
E. coli compared to pork and beef.  
The virulence potential of meat-source ExPEC was further supported by 
phylogenetic analysis of these strains. It has been suggested that the virulence of a strain 
could be better inferred from its phylogenetic background than from its commensal or 
pathogenic origin (28). Studies demonstrated that virulent extraintestinal E. coli strains 
came mostly from phylogenetic group B2, and to a lesser extent from group D (18). Our 
analysis of 200 ExPEC from retail meats revealed that many ExPEC isolates belonged to 
groups B2 and D, with a higher proportion in turkey ExPEC strains (79%) than chicken 
strains (55%) despite a similar frequency of ExPEC overall.  This implies that turkey may 
deserve greater attention than chicken with respect to the possibility of transmitting 
ExPEC. 
Our data showed that more than 80% of the meat-derived ExPEC were resistant 
to at least one of the tested antimicrobials, many of which are commonly used in clinical 
settings. For example, 10-20% of ExPEC were resistant to 
trimethoprim/sulfamethoxazole, amoxicillin/clavulanic acid, ampicillin and nalidixic 
acid, all of which are frequently prescribed antimicrobial classes in the treatment of UTIs 
(35). Resistance to two important antimicrobials, ceftriaxone and ciprofloxacin, was also 




reported because the resistance breakpoint was revised down by the CLSI from >64 
µg/ml to >4 µg/ml in January 2010 (3). Previous research suggested that resistant E. coli 
in food animals or meat may primarily derive from susceptible isolates in their animal 
host (11, 14, 19), the fact that resistant and susceptible ExPEC isolates in this study were 
similar with respect to most virulence gene carriage (except papC) and phylogenetic 
group confirmed this hypothesis.  
A strength of this study is that the E. coli isolates were recovered from retail 
meats obtained in four states over a year of testing.  To our knowledge, this is the first 
study of this extent examining randomly selected E. coli from foods over time, and may 
be considered a good preliminary assessment of ExPEC in retail meat across the U. S.  
There also are several limitations of this study.  In the NARMS retail meat program, only 
one E. coli isolate is selected from each positive meat sample. Consequently, the true 
prevalence of ExPEC in retail meat was probably underestimated. Moreover, the study 
could be more compelling if there were temporally and spatially corresponding human 
clinical ExPEC strains available for comparison. Finally, ExPEC was defined based on 
the molecular detection of more than two of the five virulence markers, yet their 
pathogenic potential was not confirmed with experimental evidence. Further 
investigations are underway in our laboratory to determine the potential of certain meat 
ExPEC in causing UTI by a more extensive virulence gene analysis and an examination 
of pathogenicity using human cell cultures.  
In summary, our results revealed that retail meats, especially poultry products, 
and to a lesser extent ground beef and pork chop, were contaminated with ExPEC that 




most ExPEC from retail meats were resistant to at least one antimicrobial agent. These 
findings indicate the potential of retail meat as a vehicle for transmitting antimicrobial-
resistant ExPEC to consumers.  Because this study relied on a limited number of markers 
to evaluate strains, further studies with more comprehensive genetic tools are needed to 
more fully elucidate the role foods may play in the epidemiology of ExPEC. 
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Targets Primer name Primer sequences (5’-3’) 
Size of product 
(bp) 
Reference 
papA PapA f ATGGCAGTGGTGTCTTTTGGTG 717 (16) 
 PapA r CGTCCCACCATACGTGCTCTTC   
papC PapC f GTGGCAGTATGAGTAATGACCGTTA 205 (16) 
 PapC r ATATCCTTTCTGCAGGGATGCAATA   
sfa/foc Sfa1 CTCCGGAGAACTGGGTGCATCTTAC 410 (16) 
 Sfa2 CGGAGGAGTAATTACAAACCTGGCA   
afa/dra Afa f GGCAGAGGGCCGGCAACAGGC 592 (16) 
 Afa r CCCGTAACGCGCCAGCATCTC   
iutA AerJ f GGCTGGACATCATGGGAACTGG 302 (16) 
 AerJ r CGTCGGGAACGGGTAGAATCG   
kpsMT II kpsII f GCGCATTTGCTGATACTGTTG 272 (16) 
 kpsII r CATCCAGACGATAAGCATGAGCA   
chuA ChuA.1 GACGAACCAACGGTCAGGAT 279 (4) 
 ChuA.2 TGCCGCCAGTACCAAAGACA   
yjaA YjaA.1 TGAAGTGTCAGGAGACGCTG 211 (4) 
 YjaA.2 ATGGAGAATGCGTTCCTCAAC   
TspE4.C2 TspE4.C2.1 GAGTAATGTCGGGGCATTCA 152 (4) 







Table III - 2. Prevalence of ExPEC and ExPEC-defining virulence markers in E. coli 
isolated from retail meats. 
 
 
No (%b) of strains positive for the indicated virulence factors / ExPEC status 
Pork chop Ground turkey Ground beef Chicken breast 
Virulence 
factors/ExPECa   
(n=180) (n=387) (n=293) (n=415) 
papA 5 (2.8) 10 (2.6) 2 (0.7) 4 (1.0) 
papC 13 (7.2) 53 (13.7)* 7 (2.4)* 44 (10.6) 
afa/dra 0 (0) 0 (0) 0 (0) 0 (0) 
sfa/foc 5 (2.8) 10 (2.6) 0 (0) 0 (0) 
iutA 33 (18.3)* 207 (53.2)* 25 (8.5)* 262 (63.1)*
kps MT II 10 (5.6)* 86 (22.2)* 9 (3.1)* 61 (14.7) 
ExPEC 15 (8.3)* 91 (23.5)* 10 (3.4)* 84 (20.2)*
a ExPEC are defined molecularly as those isolates containing two or more of the 
following genes: papA and/or papC (analyzed collectively), afa/dra, sfa/foc, iutA, kps 
MT II. 
b Percentage of positive isolates among all E. coli isolates within each meat types. 






Table III - 3. Serogroups of ExPEC isolated from retail meats. 
 
  Number of ExPEC in each serogroup 
O type Chicken Breast (n = 84) 
Ground turkey 
(n = 91) 
Ground beef   
(n = 10) 
Pork chop 
(n = 15) 
Total (%a) 
(n = 200) 
ONT 16 12 3 2 33 (16.5) 
1 3 2 1 0 6 (3) 
2 7 33 1 0 41 (20.5) 
4 0 3 0 0 3 (1.5) 
5 3 0 0 2 5 (2.5) 
6 3 1 0 0 4 (2) 
7 1 1 2 0 4 (2) 
8 2 6 0 1 9 (4.5) 
9 0 1 0 0 1 (0.5) 
11 0 9 0 1 10 (5) 
13 1 0 0 0 1 (0.5) 
15 2 1 0 0 3 (1.5) 
18 0 0 0 2 2 (1) 
19 2 4 0 0 6 (3) 
20 2 0 0 0 2 (1) 
21 3 0 0 0 3(1.5) 
25 15 4 0 0 19 (9.5) 
33 0 0 0 1 1 (0.5) 
36 1 0 0 0 1 (0.5) 
53 1 0 0 0 1 (0.5) 
55 1 0 0 0 1 (0.5) 
73 4 1 0 1 6 (3) 
78 3 1 0 0 4 (2) 
83 0 2 0 0 2 (1) 
84 1 1 0 2 4 (2) 
88 3 0 0 0 3 (1.5) 
101 0 1 0 0 1 (0.5) 
102 0 0 1 0 1 (0.5) 
103 0 1 0 0 1 (0.5) 
114 1 0 0 0 1 (0.5) 
115 1 0 0 0 1 (0.5) 
119 0 2 0 2 4 (2) 
120 2 0 0 0 2 (1) 




138 1 0 0 0 1 (0.5) 
145 0 1 0 0 1 (0.5) 
148 0 1 0 0 1 (0.5) 
153 0 1 0 0 1 (0.5) 
159 1 1 0 0 2 (1) 
168 0 0 0 1 1 (0.5) 
17,73 0 0 1 0 1 (0.5) 
19,86 3 0 1 0 4 (2) 
106, 116 1 0 0 0 1 (0.5) 
 




 Table III - 4. Distribution of phylogenetic groups among ExPEC from retail meats. 
 
 
Phylogenetic group, no. (%a) 
Source of ExPEC Total no. of ExPEC A B1 B2 D 
Chicken breast 84 24 (28.6) 13 (15.5) 28 (33.3) 19 (22.6) 
Ground beef 10 1 (10.0) 0 (0) 2 (20.0) 7 (70.0)*
Ground turkey 91 13 (14.3) 6 (6.6) 53 (58.2)* 19 (20.9) 
Pork chop 15 7 (46.7) 3 (20.0) 1 (6.7)* 4 (26.7) 
Total 200 45 (22.5) 22 (11.0) 84 (42.0) 49 (24.5) 
 
a Percentage of isolate among all ExPEC isolates from each type of meats. 





Table III - 5. Distribution of virulence factors according to phylogenetic group and 
resistance status. 
 
Prevalence of virulence factors, no. (%a) 
within phylogenetic group  Resistance status 






gene (%) n=45 n=22 n=84 n=49   (n=163) (n=37) 
papA 20 (10.0) 6 (13.3) 2 (9.1) 8 (9.5) 4 (8.2)  17 (10.4) 3 (8.1) 
papC 98 (49.0) 27 (60.0) 21 (95.5)* 22 (26.2)* 28 (57.1)  90 (55.2)* 8 (21.2) 
afa/dra 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)  0 (0.0) 0 (0.0) 
sfa/foc 13 (6.5) 3 (6.7) 1 (4.5) 8 (9.5) 1 (2.0)  9 (5.5) 4 (10.8) 
iutA 197 (98.5) 45 (100) 22 (100) 82 (97.6) 48 (98.0)  160 (98.2) 37 (100) 
kpsMT II 123 (61.5) 18 (40.0)* 1 (4.5)* 75 (89.3)* 29 (59.1)   96 (58.9) 27 (73.0) 
a: Percentage of isolates with the gene among all ExPEC within each group. 








Figure III - 1. Antimicrobial resistance of 200 ExPEC isolated from retail chicken breast, 
ground beef, ground turkey, and pork chop in 2006.  
These isolates were tested for susceptibility to: amikacin (AMI), gentamicin (GEN), 
kanamycin (KAN), streptomycin (STR), ampicillin(AMP), amoxicillin/Clavulanic acid 
(AMC), ceftiofur (TIO), ceftriaxone (AXO), cefoxitin (FOX), sulfisoxazole (FIS), 
trimethoprim/sulfamethoxazole (COT), chloramphenicol (CHL), ciprofloxacin (CIP), 

































CHAPTER IV.  CHARACTERIZATION OF POTENTIALLY 
UROPATHOGENIC ESCHERICHIA COLI STRAINS ISOLATED 
FROM RETAIL MEATS 
 
Abstract 
Although meats are generally considered as an importance source of E. coli 
strains that cause enteric infections, it was suggested recently that meats might be a 
reservoir for uropathogenic E. coli (UPEC) that cause urinary tract infections (UTIs). The 
objective of this study was to determine the uropathogenic potential of E. coli strains 
isolated from retail meat. Two hundred E. coli strains isolated from National 
Antimicrobial Resistance Monitoring System (NARMS) retail meat in 2006, which were 
previously identified as extraintestinal pathogenic E. coli, were investigated by multiplex 
PCR for the presence of 21 virulence genes that are involved in UTI pathogenesis. 
Twenty three E. coli strains were then selected and further characterized by multi-locus 
sequence typing (MLST) and assays for adherence to and invasion of human bladder 
carcinoma T-24 cells. Moreover, the ability of those strains to induce interleukin-6 
secretion from T-24 cells was also examined. Of the 21 virulence genes tested, all were 
detected in E. coli isolates except for afa/dra and hlyD.  Each isolate carried a number of 
virulence genes ranging from 2 to 13. Twenty three E. coli strains were selected for 
further analysis based on their virulence gene profiles and serotypes. Among them, 
twenty one strains were assigned to 12 specific sequence types (ST), while the remaining 
2 strains exhibited new STs. Seventeen strains belonged to STs associated with human 




and invasion compared to clinical UPEC strain CFT073. But like UPEC strain CFT073, 
all of them induced less Interleukin (IL)-6 secretion compared to E. coli K-12 strain. 
These observations suggested that a small proportion of E. coli isolates from retail meats 
resemble human UPEC in various aspects, but their potential in causing human UTI still 
needs further investigation. 
 
Introduction 
Urinary tract infections (UTIs), including cystitis and pyelonephritis, are the most 
common bacterial infections in the United States, which account for approximately seven 
billion infections per year and over $1 billion cost (6). It is estimated that 40% of women 
and 12% of men will experienced at least one episode of UTI, and vexing recurrent UTI 
are very common in many individuals (5). Uropathogenic E. coli (UPEC), which belong 
to a broader group of E. coli that cause infections outside of gastrointestinal tract 
(extraintestinal pathogenic E. coli, ExPEC), are the causative agent for 70–95% of 
community-acquired UTIs and about half of nosocomial UTIs (40). 
UPEC strains generally belong to a limited serogroups, while they don’t share 
similar pattern for H antigen and K antigen (27). Most of them are assigned to 
phylogenetic group B2 and, to a lesser extent, phylogenetic group D (34). In contrast to 
commensal strains which generally harbor no or few virulence factors, UPEC have 
evolved an array of virulence factors and mechanisms that are important in allowing them 
to establish UTI (19, 40). UPEC encode various adhesive structures called pili or 
fimbriae to help them adhere and even invade to uroepithelial cells. To survive in a low 




iron from host for their benefit. Various toxins that UPEC strains secrete are also 
involved in the UTI pathogenesis. In response to UPEC infection, human innate immune 
response is initiated, which is characterized by secretion of pro-inflammatory 
cytokines/chemokines (including IL-6 and IL-8) by urothelial cells. Production of such 
molecules is essential in rapid recruitment of neutrophils into the bladder and in clearing 
bacteria (32, 33). But it has been shown that many UPEC strains could suppress cytokine 
and chemokine production during the early stage of colonization and this may serve as 
one of the strategies that UPEC use to evade the innate immune response (3, 10).  
It is generally accepted that the immediate reservoir of UPEC is within the human 
intestinal tract (37). Due to the proximity of urinary tract to the rectum, bacteria from the 
fecal flora could seek chance to get into the urinary tract. Once inside the urinary tract, 
UPEC could ascend through the urethra into the bladder and cause cystitis. Sometimes 
bacteria could go further through ureters to kidney and cause pyelonephritis (29, 32). 
Despite the general consensus about the aforementioned pathway, the question about 
where those UPEC strains come from still remains largely unresolved. In light of the 
occurrence of UTI outbreaks due to closely related UPEC strains and the epidemiological 
association between meat consumption and UTI, it has been hypothesized that foods, 
especially meat, could be a possible reservoir of human UPEC strains (28, 35, 39). In 
many research testing this hypothesis, different methods were employed to determine 
similarity of meat-derived E. coli strains to clinical UPEC strains (16, 39). But none of 
them examined the virulence potential of meat-derived isolates by using tissue cultures or 
animal models. In this study, 200 E. coli isolates from retail meat, which were previously 




Selected isolates were subtyped by multi-locus sequencing typing (MLST). Furthermore, 
selected isolates were investigated for their ability to adhere to and invade bladder 
epithelial cells, and their ability to induce IL-6 secretion by T-24 cells was also explored. 
 
Materials and methods 
Bacterial strains.  Two hundred E. coli isolates, including 84 from chicken 
breast, 91 from ground turkey, 10 from ground beef, and 15 from pork chop, were 
selected from 1, 275 E. coli isolates recovered from meat samples by the National 
Antimicrobial Resistance Monitoring Systems retail meat program in local grocery stores 
in Geogia, Maryland, Oregon and Tennessee from January to December 2006. All of 
isolates were selected based on their ExPEC status, which was defined by possession of 
two of more of the following five virulence markers: papA or papC, sfa/foc, afa/dra, 
kpsMT II and iutA. All of those isolates have been characterized for serogoup and 
phylogenetic group previously, and such information was included in this study for a 
comprehensive view of all available characteristics of each isolate and for selection 
purpose. Control strains used for genotyping were clinical E. coli strains JJ079, Buti 1-5-
1, Buti 1-7-6, V27, 2H16 (all of strains were kindly provided by Dr. James R Johnson of 
the University of Minnesota). A UPEC strain CFT073 and a laboratory E. coli strain K-
12 were used as reference strains in tissue culture studies. All strains were stored at – 
80°C in LB broth with 20% glycerol until use. 
DNA preparation. E. coli cells were recovered from frozen culture at – 80°C, 
streaked onto blood agar plate and incubated overnight at 37 °C. For virulence 




method (42). Alternatively, for MLST analysis, DNA was prepared from each of the 
isolates with an UltraClean Microbial DNA Isolation kit (MoBio Laboratories, Solana 
Beach, CA) used according to the manufacturer’s instructions. 
Virulence genotyping.   Twenty one virulence genes associated with UPEC 
pathogenesis were investigated by three multiplex PCR assays. Targeted genes and their 
descriptions are given in Table 1 . Primers for each virulence factor were first validated 
individually in single PCR assays. Then primers were placed into three pools according 
to primer compatibility and product size: Pool 1: hra, papG allele III , usp, fimH, iha, sat; 
Pool 2, papG allele II, pic, cnf1, ompT, cvaC, pai; Pool 3: papC, kpsMT II, iutA, sfa/foc, 
afa/dra, papA, hlyD. Primer pools were tested by use of control strains containing all the 
relevant virulence genes. For pool 1, E. coli strain JJ079 and Buti 1-5-1; pool2, E. coli 
strain 079, Buti 1-5-1 and Buti 1-7-6, pool 3: E. coli strain V27 and 2H16. (all of these 
strains were kindly provided by Dr. James R Johnson of the University of Minnesota).  
All multiplex PCR were performed in a 25 µl reaction mixture containing 2 µl of 
template DNA, 2.5 µl of 10 × PCR buffer, 2 µl of a 1.25 mM mixture of deoxynucleoside 
triphosphates, 4 µl of 25 mM MgCl2, 0.25 µl of 5 U of AmpliTaq Gold DNA polymerase 
(Applied Biosystems, Branchburg, NJ), and a 0.6 µM concentration of each primer 
(Invitrogen, Carlsbad, CA). The thermocycling conditions were as follows: 95°C for 12 
min, 94°C for 30 s, 60°C for 30 s, and 68°C for 3 min for 30 cycles, with a final 10 min 
extension at 72°C (13). PCR products (10 µl) were evaluated with a 2 % (wt/vol) agarose 
gel at 120 mV for 30 min. A molecular marker (100 bp DNA ladder; New England 
BioLabs, Ipswich, MA) was run concurrently. An isolate was considered to contain 




Multilocus sequence typing.  MLST of selected E. coli strains were carried out 
by performing a sequence analysis of seven housekeeping genes (adk, fumC, gyrB, icd, 
mdh, purA, and recA) using the typing scheme described before (1, 41). Fragments of 
seven genes were amplified using specific primers listed in Table 1. The PCR amplicons 
were purified and then sequenced on both strands with the PCR primer set. Sequencing 
reactions were performed using Big-dye terminator cycle sequencing ready reaction DNA 
sequencing kit and electrophoresed on AB 3730 DNA sequencer (Applied Biosystems, 
Foster City, CA).  DNA sequence data were compiled and analyzed using DNA 
Sequencher 4.0 software (Gene Codes Corp., Ann Arbor, MI).  Assignment of the alleles, 
sequence types and sequence type complexes were performed via an electronic E. coli 
MLST database (http://mlst.ucc.ie/mlst/dbs/Ecoli). 
Adherece and invasion assays.   Adherence and invasion assays were performed 
according to procedures described previously with some modifications (24, 30). Briefly, 
T-24 human bladder epithelial cells were grown into confluent epithelial cell monolayer 
in 24-well plates. Bacteria, grown statically in LB broth at 37 °C for 24 h, were diluted 
with phosphate-buffered saline (PBS) to achieve an optical density at 600nm (OD600) of 
0.5. Ten microliter of bacterial suspension (a multiplicity of infection (MOI) of about 10) 
was added to three sets of triplicate cells. The number of cells in inoculum was titered by 
serial dilution. After incubation at 37 °C for 2 h, the cells in one set of wells were washed 
five times with PBS (containing Mg2+ and Ca2+ )(Gibco), and lysed in  1 ml 0.1% Triton 
X-100 in H2O to calculate the number of adherent bacteria. In another set of wells, 20 µl 
of 5% Triton X-100 was added to lyse the cells, and the total number of bacteria was 




recovered after PBS washes divided by the total number of bacteria present in each well. 
To determine invasion frequency, a third set of triplicate wells was washed twice with 
PBS (containing Mg2+ and Ca2+), and incubated for another 2 h in medium containing 
100 µg/ml gentamicin (Sigma) to kill all extracellular bacteria. Cells were then washed 
with PBS (containing Mg2+ and Ca2+) three times, and lysed in 1 ml of 0.1% Trion X-100 
in water to enumerated intracellular bacteria. The percent invasion frequency was 
expressed as the number of the bacteria surviving the gentamicin treatment divided by the 
number of bacteria in the initial inoculum.  
IL-6 Cytokine induction assay.  IL-6 scretion assays were performed essentially 
as described by Hunstad et al (11). Confluent epithelial T-24 cell monolayers were 
prepared as described above. Confluent bladder cell monolayers were washed once with 
sterile phosphate-buffered saline (PBS), and 990 µl of fresh medium was added. Ten 
microliters of bacterial suspension (MOI of about 10) were added to corresponding wells. 
Uninfected wells (in which 10 µl PBS was added) were used as control. After 
inoculation, tissue culture plates were incubated at 37°C with 5% CO2 for 2 h. Culture 
supernatants were then collected, centrifuged at 20,000 g for 3 min to pellet bacteria and 
cell debris, and stored at -80°C until IL-6 measurement by using human IL-6 ELISA kit 
(R & D Systems, Minneapolis, MN). 
Statistical analysis. All analyses were performed by use of Statistical Package for the 
Social Sciences (SPSS) version 11.0. Comparisons of proportions for a virulence gene in 
different groups were tested by Chi-square test (2-tailed). And comparisons of the 
difference in the number of virulence gene between groups were tested by Kruskal-Wallis 




means were tested with one-way analysis of variance followed by Dunnett’s multiple 
comparisons test. The threshold for statistical significance was P < 0.05. 
 
Results 
Virulence genotyping of ExPEC strains from retail meats.  Of the 21 virulence 
genes tested, all could be detected in E. coli strains isolated from retail meats except 
afa/dra gene and hlyD gene. Other genes occurred at rates ranging from 0.5% to 97.5% 
(Table 2). Nearly all isolates harbored the fimH gene, and some adhesion genes such as 
papG allele II and hra were present in 38.0% and 33.5% of the isolates, while papG 
allele III and iha were only found in a small percentage of the isolates (2.0% and 3.5% 
respectively). Iron acquisition genes, iutA and iro, were very frequently present in those 
meat-source isolates (80.5% and 98.5%). Protectins genes, such as cvaC and kpsMT II, 
were detected in more than half of the isolates. Among the five toxins examined, only vat 
and pic were relative common, while cnf1 and sat occurred in 0.5% of all isolates and no 
isolates contained hlyD gene. For miscellaneous virulence genes, ompT was found in 
76.0% of all isolates, malX and usp were present in 43% and 36% of all isolates. Certain 
virulence genes, including cvaC, kpsMT II, vat, ompT, malX and usp, were associated 
with phylogenetic group B2 (Table 2). Genes iro, cvaC,malX and usp occurred in a 
higher percentage of turkey isolates than isolates from other three types of meats (Table 
2).  
The number of virulence genes detected in different strains ranged from 2 to 13 
among the 21 genes tested. The average number of virulence genes in those meat-derived 




previous research revealed that isolates belonging to phylogenetic group B2 (8.9) and D 
(7.7) contained higher number of virulence genes compared to strains in group B1(6.2) 
and A (5.7) (data not shown). Isolates from different meat types did not differ 
significantly in the number of virulence genes they contained. 
MLST.  Twenty three E. coli strains were selected from 200 E. coli isolates for 
MLST analysis based on their virulence gene profile (≥8 genes) and serotypes being one 
of the 10 common serogroups in E. coli causing UTI (Table 3). Of 23 strains analyzed by 
MLST, twenty one strains could be assigned to 12 specific sequence types (ST), while the 
remaining two strains exhibited new STs that could not be assigned a type by the E. coli 
MLST website (Table 4). Two isolates belonged to ST73 which was included in ST73 
complex. One isolate was identified as ST140 and two were found to be ST95, all of 
them were placed into ST95 complex. One isolate was identified as ST88 and fell into 
ST23 complex. Other STs identified among 23 isolates were ST131(3 isolates), ST998 (3 
isolates), ST117 (2 isolates), ST141 (2 isolates), ST429 (2 isolates), ST88 (1 isolates), 
ST135 (1 isolates), ST624 (1 isolates),ST770 (1 isolates), none of them could be placed 
in any ST complexes in the database. 
Adherence and invasion. Since adherence and invasion are considered as 
important steps during UPEC pathogenesis, 23 strains were further tested for adherence 
and invasion using T-24 bladder carcinoma cell line together with a human UTI strain 
CFT073 and a laboratory strain K-12. All isolates from meat could adhere to T-24 cell to 
some extent, with the percentage of adherence ranged from 0.125% to 1.022% (Figure 1). 
Both CFT073 and non-virulent strain K-12 showed strong adherence to T-24 cell, while 




adherence assay, meat-source isolates also exhibited various degree of invasiveness. 
Based on the results of non-invasive E. coli K-12 strain, meat-source isolates were 
categorized into three groups according to their invasion percentage: non-invasive (0-
0.05%), potentially invasive (0.05-0.1%) and invasive (>0.1). According to this criterion, 
only 1 isolate was considered as invasive, six isolates as potentially invasive, and 16 
isolates were put into non-invasive group. 
Cytokine secretion assay.  It was demonstrated that most clinical UPEC isolates could 
suppress pro-inflammatory cytokine secretion by bladder epithelial cells. In order to 
determine whether strains from retail meat could modulate urothelial IL-6 response, we 
infected T-24 cells with E. coli isolates from meat and quantified IL-6 secretion by 
ELISA. Clinical strain CFT073 (117.03 ± 38.73pg/ml) induced significantly less IL-6 
compared with K-12 (244.12 ± 22.15  pg/ml) strain. Similar to CFT073, all meat-source 




Although it is generally accepted that UPEC strains causing UTIs come from the 
patients’ colon, the actual source of those pathogenic strains remains elusive. Recent 
studies suggested that UPEC may originate from contaminated food, especially animal-
derived product (14, 16, 18, 39). To test this hypothesis, we investigated E. coli isolates 
from four different types of meats for an array of UPEC virulence genes. And those 
strains with a high number of virulence genes were chosen for MLST typing and their 




that E. coli isolates from retail meats contained many UPEC virulence genes, and some of 
them belonged to STs that were involved in human UTIs. But the lack of certain 
archetypal UPEC virulence gene and poor ability to adhere to and invade epithelial cells 
indicated that the hypothesis of animal reservoir of UPEC still needs more evidence. 
The roles of most of virulence genes chosen in this study were experimentally 
determined in the pathogenesis of UTI (17, 29). Except for afa/dra and hlyD, all of 
virulence genes were detected in meat-derived isolates including certain very typical 
UPCE virulence genes such as P, S, G fimbriae, and the usp gene, indicating at least 
those strains may serve as a reservoir of  UPEC virulence genes  that could be transferred 
to microflora in the human intestine. On the other hand, E. coli from meats lacked some 
virulence genes commonly found in UPEC isolates such as hlyD and cnf1, which were 
estimated to be present in one third and half of UPEC isolates, respectively (40). And for 
those virulence genes present in isolates from meat, their prevalence was different from 
the data in studies examining UPEC isolates (23, 36). For instance, iha, papA, papG III, 
vat and malX were found to be in a higher percentage in UPEC isolates, while higher rate 
of iro and cvaC were observed in meat-source isolates than in UPEC isolates (23). Those 
findings suggest that although there is overlap with respect to virulence genes among 
meat-source isolates and UPEC isolates, their distributions differ. Our results are very 
similar to other studies examining virulence gene profiles of ExPEC isolates from meats 
in spite of different sampling time and locale. Johnson et al. examined several virulence 
factors in ExPEC isolates from a more geographically limited retail chicken  samples, 
very similar levels of afa/dra, fimH, papC, iro,iutA, cvaC, kpsMT II,cnf1, hlyD, ompT, 




in prevalence data indicates that it is the general picture of the presence of UPEC 
virulence genes in E. coli from retail chicken. 
Isolates belonging to phylogenetic groups B2 and D have higher number of 
virulence genes (8.9 for B2 and 7.7 for D) than isolates from group A (5.7) and B1 (6.2). 
This confirmed the perception that strains in those two phylogenetic groups were 
generally more virulent than the other two groups (34). Many studies demonstrated that 
most UPEC isolates fell into those two groups (15, 20). Although many researchers 
focused on poultry products for meat reservoir hypothesis (18, 39), our results showed 
that pork or beef isolates also bear certain UPEC virulence genes. And some adhesin 
genes occurred at higher rates in isolates from these two groups than from poultry 
products (such as iha, hra, papA, papG III and sfa/foc). Even though only a small 
percentage of E. coli isolates from these two types of meat met ExPEC criteria (that is 
why a low number of isolates were available to be included in this study), their potential 
as a UPEC reservoir could not be completely excluded. 
It was suggested that the number of virulence genes present in an isolate could be 
a good predictor of its virulence (15). So we chose 23 strains that contained more than 8 
virulence genes and belonged to the common ten O groups in UPEC, with the assumption 
that they have higher chance of being urovirulent, and they were subjected to MLST 
analysis. Many typing methods have been used to identify clonal groups among UPEC. 
One useful technique is MLST, which utilized variations of several house keeping genes 
for comparison and therefore, avoid the drawbacks of gel-based fingerprinting method 
(41). In addition, there is a large collection of UPEC in globally accessible MLST 




selected isolates by MLST revealed that many of them belonged to ST complexes that 
included clinical UPEC strains. For instance, ST95 complex and ST73 complex are two 
of the four major ST complexes (another two are ST14 complex and ST69 complex) that 
are associated with human UPEC in the U.S. (25). Other STs, such as ST88, ST117, 
ST131, ST141, ST770, and ST998 were also reported to be involved in UTIs in the 
MLST database. This overlap of ST among meat and human isolate implied that certain 
E. coli isolates from meat may have zoonotic potential. 
Although several researchers have also investigated virulence gene profiles and 
examined genetic similarity between meat-source isolates and human clinical isolates 
with different typing methods, none of them explore the virulence potential of those 
isolates using tissue culture or animal model (12, 23, 39). Here we used T-24 cells, a 
commonly used human bladder carcinoma epithelial cell, to assess the interaction 
between meat-derived isolates and bladder cells. Adherence was the first step of UTI 
pathogenesis and is very important for strain to persist in bladder. In addition, UPEC 
could invade into epithelial cells to form intracellular communities, which may shield the 
bacteria from the host immune response (32).  Unexpectedly, even though some meat 
isolates did harbor several virulence genes including various adhesion genes, they were 
generally not good at attaching, and most of them fell into non-invasive group, both of 
which may indicate that their potential to cause UTI are limited. This incongruence of 
genotype with phenotype may be explained by the fact that many of the virulence genes 
in those meat isolates may not be or are weakly expressed. Researchers has found that 
even though almost 90% of E. coli contains the fimH gene, which encode the tip of type 1 




switch element. Difference in fim switch status (on or off, also known as phase variation) 
was found between UPEC compared and control isolates (8, 26). Admittedly, UPEC are 
comprised of a very heterogeneous group of strains and poor adhesion and invasion do 
not necessarily equal to no potential to cause UTI (31).  So even though meat isolates 
have low adherence and invasion ability, the possibility for them to cause human disease 
still exists. 
Upon UPEC infection, host bladder epithelial cells respond by secreting cytokines 
and chemokines, leading to inflammation and clearance the bacteria. Recent studies 
demonstrate that during the early stage of colonization, UPEC could modulate this 
response and may provide themselves more time to colonize and multiply (2, 3, 10). 
Since this seems to be an important characteristic in UPEC, we were interested to see if 
E. coli isolates from meat could behave like UPEC. Surprsingly, like the clinical strain 
CFT073, all meat isolates induced less IL-6 compared with K-12 strain. This may bring 
into question the use of this character to predict uropathogenic potential. Billips et al. 
investigated a panel of human E. coli strains including diarrheagenic strains, fecal strains 
and ExPEC strains, and they found that most of those strains could modulate IL-6 
secretion irrespective of their origins. It is possible that this trait may give those 
pathogenic strains additional advantage during colonization, but it could also be shared 
by other pathogenic or commensal strains.  
In summary, we demonstrated that a small proportion of E. coli strains isolated 
from retail meats contained UPEC virulence genes and shared ST with clinical UPEC, 
indicating their potential to be a reservoir of UPEC virulence genes or even UPEC. But 




undetermined. More research (such as infection study using animal models) is warranted 
before we could conclude with full confidence that meat reservoir exists for UPEC. 
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Table IV - 1 Primers used for virulence gene detection and MLST analysis. 
Gene Description Size (bp) Primer sequences (5' - 3')  
      
Reference 
Adhesins 
afa/dra Dr antigen-specific fimbrial 
and afimbrial adhesin 
592 F: ggcagagggccggcaacaggc  
R: cccgtaacgcgccagcatctc 
(21) 
fim Type 1 fimbriae 508 F: tcgagaacggataagccgtgg  
R: gcagtcacctgccctccggta 
(21) 
hra Heat-resistant agglutinin 162 F: cgaatcgttgtcacgttcag 
R: tatttatcgccccactcgtc 
(38) 
iha Iron regulated gene homolog 
adhesin 
829 F: ctggcggaggctctgagatca  
R: tccttaagctcccgcggctga 
(36) 
papA Major structural subunit of P 
pili 
717 F: atggcagtggtgtcttttggtg  
R: cgtcccaccatacgtgctcttc 
(21) 
papC Central region of P pili  205 F: gtggcagtatgagtaatgaccgtta  
R: atatcctttctgcagggatgcaata 
(21) 





Class III P pili 258 F: ggcctgcaatggatttacctgg 
R: ccaccaaatgaccatgccagac 
(21) 
sfa/foc Central region of S fimbriae 
and F1C fimbriae 


















Group II capsular 
polysaccharide synthesis 




cnf1 Cytotoxic necrotizing   factor 
1 
498 F: aagatggagtttcctatgcaggag  
R: cattcagagtcctgccctcattatt 
(21) 
hlyD Transporter gene of the 
hemolysin operon 
904 F: ctccggtacgtgaaaaggac  
R: gccctgattactgaagcctg 
(36) 
pic Serin protease 
autotransporter 
409 F: actggatcttaaggctcagg  
R: tggaatatcagggtgccact 
(4) 
sat Secreted autotransporter 
toxin 
937 F: gcagctaccgcaataggaggt  
R: cattcagagtaccggggccta 
(7) 
vat Vacuolating autotransporter 
toxin 









ompT Outer membrane protease 559 F: atctagccgaagaaggaggc  
R: cccgggtcatagtgttcatc 
(36) 
malX  Pathogenicity-associated 
island marker  
925 F: ggacatcctgttacagcgcgca   
R: tcgccaccaatcacagccgaac 
(21) 




adk Adenylate kinase  583 F: attctgcttggcgctccggg 
R: ccgtcaactttcgcgtattt 
(41) 
fumC Fumarate hydratase  806 F: tcacaggtcgccagcgcttc 
R: gtacgcagcgaaaaagattc 
(41) 
     





799 F: ccgattatcccttacattgaag  
R: ggacgcagcaggatctgtt 
(1) 





816 F: cgcgctgatgaaagagatga  
R: catacggtaagccacgcaga 
(41) 












Prevelance of virulence associated genes in ExPEC from meats (%) 
Meat type  Phylogenetic group 
Chicken  beef  turkey Pork  A  B1 B2 D 
Genes/categories 
Overall  
n = 84 n = 10 n = 91 n = 15 n = 45 n = 22 n = 84 n = 49 
Adhesins           
afa/dra 0.0  0.0  0.0  0.0  0.0   0.0  0.0  0.0  0.0  
fimC 97.5  96.4  100.0 100.0  86.7   88.9  100.0  100.0  100.0  
hra 33.5  41.7  80.0  18.7  46.7   40.0  22.7  23.8  49.0  
iha 3.5  4.8  0.0  1.1  13.3   0.0  4.5  4.8  4.1  
papA 10.0  4.8  20.0  9.9  33.3   13.3  9.1  9.5  8.2  
papC 49.0  51.2  50.0  40.7  86.7   60.0  95.5  26.2  57.1  
papGII 38.0  44.0  30.0  33.0  40.0   40.0  72.7  20.2  51.0  
papGIII 2.0  2.4  0.0  0.0  13.3   4.4  9.1  0.0  0.0  
sfa/foc 6.5  0.0  0.0  11.0  20.0   6.7  4.5  9.5  2.0  
Iron acquisition           
iro 80.5  67.9  70.0  96.7  60.0   62.2  81.8  88.1  83.7  
iutA 98.5  100.0  100.0 97.8  93.3   100.0 100.0  97.6  98.0  
Protectins 0.0  0.0  0.0  0.0  0.0   0.0  0.0  0.0  0.0  
cvaC 68.5  50.0  60.0  93.4  26.7   42.2  68.2  81.0  71.4  
kpsII 61.5  57.1  70.0  69.2  33.3   40.0  4.5  89.3  59.2  
Toxins           
cnf1 0.5  0.0  0.0  1.1  0.0   0.0  0.0  1.2  0.0  
hlyD 0.0  0.0  0.0  0.0  0.0   0.0  0.0  0.0  0.0  
pic 15.5  7.1  40.0  17.6  33.3   0.0  4.5  15.5  34.7  
sat 0.5  0.0  0.0  0.0  6.7   0.0  0.0  1.2  0.0  
vat 38.5  21.4  50.0  54.9  26.7   6.7  4.5  63.1  40.8  
Miscellaneous           
ompT 76.0  67.9  80.0  84.6  66.7   55.6  36.4  96.4  77.6  
pai 43.0  29.8  20.0  63.7  6.7   6.7  0.0  83.3  26.5  






            



















M # of VF 
N11989                       Turkey 1 B2 - + + + - - + + - - + + + + + - + + 12
N12528                       
                       
                       
                       
                       
                       
                       
                       
                       
                       
                       
                       
                       
                       
                       
                       
                       
                       
                       
                       
                       
                       
Chicken 1 D + - + + - - - + + - + - + - - - + + 9
N11444 Turkey 2 B2 + + + + - - - + + + + + + - - + + + 13
N12522 Chicken 2 B2 + + + + - - + + - - + + + - + - + + 12
N11698 Turkey 2 B2 - + + + - - - + + - + + + - - + + + 11
N11726 Turkey 2 B2 + + + + - - - + + - + - + - - + + + 11
N11816 Turkey 2 B2 - + + + - - - + + - + + + - - + + + 11
N12564 Turkey 2 B2 - + + + - - + - - - + + + + + - + + 11
N11911 Chicken 2 D + - + + - - + - - - + + + - + - + + 10
N11479 Turkey 2 B2 - + + + - - - + + - + + + - - - + + 10
N11279 Turkey 2 B2 - + + + - - - + - - + + + - - - + + 9
N12138 Turkey 2 B2 - + + + - - - + - - + + + - - - + + 9
N11940 Turkey 2 B2 - + + + - - - + - - + + + - - - + + 9
N11306 Turkey 4 B2 - + + + - - - + + - + + + - - + + - 10
N12064 Turkey 6 B1 - - + + - - + + + - + + - - + - + - 9
N12306 Beef 7 D + - + + - - - + + - + + - - - - + + 9
N12521 Chicken 8 B2 - + + + + - - + - - + + + - - - + + 10
N11981 Chicken 8 A + - + + - - + - - - + + - - + - + - 8
N12050 Pork 18 B2 + + + - + + - + + - + - + - - - + + 11
N11610 Chicken 25 B2 + + + + - - - - - - + + + - - - + + 9
N11473 Chicken 25 B2 - + + + - - - - - - + + + - - - + + 8
N11668 Chicken 25 B2 + - + + - - + - - - + - - - + - + + 8
N12423 Chicken 25 B2 - + + + + - - - - - + - + - - - + + 8
*: None of these isolates contained papGIII, hlyD and afa/dra.
Abbreviations: serogroup (sero), phylogenetic group (phylo), virulence factor (VF)  
 
 
Table IV - 4. MLST of 23 E. coli isolates from retail meats. 
 
Gene allele type 
Isolate 
adk fumC gyrB icd mdh purA recA 
ST ST Complex 
N12528 6 4 14 16 24 2 14 New None 
N12521 27 88 78 29 70 158 2 New None 
N11306 36 24 9 13 17 11 25 ST073  ST73 Cplx  
N12050 36 24 9 13 17 11 25 ST073  ST73 Cplx  
N11981 6 4 12 1 20 12 7 ST088  ST23 Cplx  
N11989 37 38 19 37 17 11 26 ST095  ST95 Cplx  
N12564 37 38 19 37 17 11 26 ST095  ST95 Cplx  
N12064 20 45 41 43 5 32 2 ST117  None  
N12306 20 45 41 43 5 32 2 ST117  None  
N11610 53 40 47 13 36 28 29 ST131  None  
N11473 53 40 47 13 36 28 29 ST131  None  
N12423 53 40 47 13 36 28 29 ST131  None  
N12522 13 39 50 13 16 37 25 ST135 None 
N12138 55 38 19 37 17 11 26 ST140  ST95 Cplx  
N11698 13 52 10 14 17 25 17 ST141  None  
N11816 13 52 10 14 17 25 17 ST141  None  
N11479 97 40 93 13 23 28 66 ST429  None 
N11940 97 40 93 13 23 28 66 ST429  None  
N11911 92 4 87 96 70 58 91 ST624  None  
N11668 52 116 55 101 113 40 38 ST770  None  
N11444 13 52 156 14 17 25 17 ST998  None  
N11726 13 52 156 14 17 25 17 ST998  None  




 Figure IV - 1. The ability of E. coli isolates from retail meat to adhere to (A) and 
invade (B) T-24 human bladder epithelial cells.  
A UPEC strain CFT073 and a laboratory strain K-12 were also included. All data 











CHAPTER V.  SUMMARY 
 
 
Food serves as a common vehicle for transmitting certain pathogens. Retail 
meat may be contaminated with E. coli during slaughtering and processing. Due to 
the fact that not all E. coli are pathogenic to human beings, differentiation between 
pathogenic and non-pathogenic strains becomes very important. Although E. coli has 
been isolated from retail meat and their prevalence was previously researched, few 
data exist about contamination of different pathogenic E. coli among retail meat. In 
this project, pathogenic E. coli strains, including both diarrheagenic and 
extraintestinal pathogenic strains, were identified from E. coli isolates recovered from 
different types of retail meats. They were further characterized genotypically and 
phenotypically in various aspects and their pathogenic potential were also 
investigated. This study would be great helpful for us to estimate the actual existence 
of different pathogenic E. coli among retail meat products in the United States and the 
potential they have to cause human disease. In addition, this study would also provide 
useful information for meat industries as well as governmental institutions controlling 
food safety. 
In chapter 2, a total of 7,259 Escherichia coli isolates collected during 2002-
2007 from NARMS retail meats (ground beef, ground turkey, chicken breast and pork 
chop) were screened for the presence of Shiga toxin genes and 1,275 E. coli isolates 
recovered in 2006 were also examined for virulence genes specific for other five 
groups of diarrheagenic E. coli. PCR assays specific for eae and EHEC-hlyA genes 
were employed to identify virulence factors of STEC, while serotyping, Vero cell 




(PFGE) were used to further characterize the STEC strains. The data demonstrated 
that diverse STEC strains were present in retail meats, especially in ground beef, and 
some strains contained stx variant that is associated with severe human infections. 
Retail meat may also be contaminated with atypical EPEC strains, while EIEC, ETEC 
and DAEC may not be a major concern in retail meat. 
 Although meats are generally considered as an importance source of E. coli 
strains that cause enteric infections, it was suggested recently that meats might be a 
reservoir for ExPEC strains. In chapter 3, the 1,275 E. coli isolates recovered in 2006 
were investigated for the presence of five ExPEC virulence markers using multiplex 
PCR. Identified ExPEC isolates were characterized by serogrouping and phylogenetic 
grouping, and their antimicrobial susceptibility data were analyzed. Approximately 
16% (200/1,275) of the E. coli isolates were identified as ExPEC based on defined 
molecular criteria. The prevalence of ExPEC was higher in the E. coli population 
isolated from poultry than E. coli from pork chop and ground beef. Most ExPEC 
isolates fell into virulent phylogenetic groups B2 and D. A large proportion of ExPEC 
isolates (81.5%) were resistant to at least one antimicrobial, and 57% of isolates 
exhibited resistance to at least three drugs. These findings showed that retail meats, 
especially in chicken and turkey products could be contaminated with ExPEC, 
including antibiotic resistant ExPEC strains. It provided the evidence for  the 
hypothesis that  retail meat may serve as a possible vehicle to transmit ExPEC strains.  
Those ExPEC found in retail meat were only defined by detection of more 
than two of the five virulence factors, yet their pathogenic potential was still largely 




bladder cells could shed more light on their potential to cause human urinary tract 
infections. In chapter 4, 200 ExPEC strains previously identified from retail meat 
were investigated by multiplex PCR for the presence of an array of virulence genes 
that are involved in UTI pathogenesis. Those strains with a high number of virulence 
genes were chosen for MLST typing and their interactions with tissue cultured human 
bladder epithelial cells were examined. Moreover, the abilities of those strains to 
induce interleukin-6 secretion from T-24 cells were also examined. It was 
demonstrated that E. coli isolates from retail meats contained many UPEC virulence 
genes, and some of those isolates belonged to STs that were frequently involved in 
human UTIs. But the lack of certain archetypal UPEC virulence gene and poor ability 
to adhere to and invade epithelial cells indicated that the hypothesis of animal 
reservoir of UPEC still need more evidence. 
In summary, this project demonstrated that a certain portion of E. coli isolates 
from retail meats are potentially diarrheagenic or extranintestinal pathogens based on 
the virulence genes they contained and their similarities to strains causing human 
infections with respect to some important characteristics. Due to the limitations of 
this project, there are still many gaps in our knowledge of meat-derived E. coli for 
future research to fill. First, although we investigated the presence of pathogenic E. 
coli against the background of generic E. coli populations, the prevalence of 
pathogenic E. coli in retail meats could not be determined. Future work specifically 
designed to isolate the specific pathotypes of E. coli from meats are necessary to 
answer the aforementioned question. Furthermore, the pathogenic potential of the E. 




infection studies will be important to elucidate the actual ability of those E. coli 
strains to cause infections. Finally, the virulence factors chosen to define ExPEC were 
epidemiologically linked with ExPEC but not unique to ExPEC. Availability of whole 
genome sequence of more clinical ExPEC strains and bioinformatics tools may help 
find certain virulence markers exclusively occurring in ExPEC and contribute to 
elucidate the real source and transmission pathway of human ExPEC strains. 
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